WO2005051280A2 - Method and apparatus for controlling a ventilator - Google Patents

Method and apparatus for controlling a ventilator Download PDF

Info

Publication number
WO2005051280A2
WO2005051280A2 PCT/US2004/035393 US2004035393W WO2005051280A2 WO 2005051280 A2 WO2005051280 A2 WO 2005051280A2 US 2004035393 W US2004035393 W US 2004035393W WO 2005051280 A2 WO2005051280 A2 WO 2005051280A2
Authority
WO
WIPO (PCT)
Prior art keywords
patient
peep
value
ratio
oxygen
Prior art date
Application number
PCT/US2004/035393
Other languages
French (fr)
Other versions
WO2005051280A3 (en
Inventor
Fleur T. Tehrani
Original Assignee
Tehrani Fleur T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34594521&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2005051280(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tehrani Fleur T filed Critical Tehrani Fleur T
Priority to CA2545570A priority Critical patent/CA2545570C/en
Priority to NZ546941A priority patent/NZ546941A/en
Priority to AU2004292955A priority patent/AU2004292955B2/en
Priority to GB0611065A priority patent/GB2423721B/en
Publication of WO2005051280A2 publication Critical patent/WO2005051280A2/en
Publication of WO2005051280A3 publication Critical patent/WO2005051280A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/021Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
    • A61M16/022Control means therefor
    • A61M16/024Control means therefor including calculation means, e.g. using a processor
    • A61M16/026Control means therefor including calculation means, e.g. using a processor specially adapted for predicting, e.g. for determining an information representative of a flow limitation during a ventilation cycle by using a root square technique or a regression analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0051Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes with alarm devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0057Pumps therefor
    • A61M16/0063Compressors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0208Oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/20Blood composition characteristics
    • A61M2230/205Blood composition characteristics partial oxygen pressure (P-O2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/40Respiratory characteristics
    • A61M2230/43Composition of exhalation
    • A61M2230/432Composition of exhalation partial CO2 pressure (P-CO2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/40Respiratory characteristics
    • A61M2230/43Composition of exhalation
    • A61M2230/435Composition of exhalation partial O2 pressure (P-O2)

Definitions

  • the present invention relates to a method and apparatus for controlling a ventilator such as a mechanical ventilator (i.e. an artificial respirator) or a respiratory assist device.
  • a ventilator such as a mechanical ventilator (i.e. an artificial respirator) or a respiratory assist device.
  • the present invention relates to a method and apparatus for controlling a ventilator based on the measured levels of oxygen of the patient on the ventilator, as well as other physical conditions of the patient.
  • the present invention describes a method and apparatus that can reliably and robustly control PEEP (or CPAP), and F t o 2 .
  • PEEP or CPAP
  • F t o 2 novel features which significantly improve the oxygenation of patients during ventilatory therapy provided by mechanical ventilators as well as respiratory devices such as CPAP machines.
  • the I:E ratio of the patient can be automatically adjusted and by further inclusion of the features of US Patent No. 4,986,268, the breathing frequency, and tidal volume can be automatically controlled in mechanical ventilation.
  • Application of these features results in a significantly more effective and optimal treatment to the patient based on his/her conditions and requirements, in total or assist ventilatory therapy.
  • a method and apparatus for controlling a ventilator includes first means receiving at least input data indicative of the patient's measured oxygen levels, and in a more elaborate embodiment of the invention, the first means also receives respiratory mechanics and/or pressure- volume data, as well as data indicative of measured carbon dioxide levels of the patient.
  • the first means which preferably comprises a programmable microprocessor, is controlled by a software algorithm to operate on the input data, and to provide digital output data to control the ventilator and the gas mixer of the ventilator.
  • the software algorithm is divided into two control programs.
  • One control program which can either be used by itself or along with the other program, is designed to automatically adjust F ⁇ ) 2 and PEEP (or CPAP), based on at least the measured oxygen levels of the patient.
  • the control program also operates on data from a pressure volume (PV) monitor/analyzer to set the initial PEEP value in certain groups of respiratory patients.
  • the processing means detects hazardous conditions based on the input data and/or artifacts, replaces and/or corrects the measurement artifacts, and instructs generation of appropriate warning signals.
  • the other control program most of which is described in US Patent No.
  • 4,986,268 is designed to control the frequency and ventilation for a next breath of the patient on the ventilator based on at least data indicative of measured CO 2 and O 2 levels of the patient, barometric pressure (as a reference pressure), and respiratory elastance and airway resistance (respiratory mechanics) data; and to make necessary adjustments in the I:E ratio based on the patient's respiratory mechanics data.
  • the output data from the 1 st means indicative of PEEP (or CPAP), F 102 , the adjustment in the I:E ratio, breathing frequency, and ventilation, and status of alarms are transmitted to a Signal Generator which is equipped with converters and/or other electronic components to generate the control and appropriate warning signals.
  • the control signals for the breathing frequency, ventilation, PEEP (or CPAP), and the adjustment in the I:E ratio are supplied to the ventilator.
  • the control signal for F ⁇ )2 is supplied to a mixer regulator unit which adjusts the concentration of oxygen added to the inhalation gas in the gas mixer of the ventilator. Based on the instructions from the 1 st means, the alarm circuit generates appropriate warning signals when needed.
  • FIGS 1-4 illustrate a preferred embodiment of the present invention. However, it is understood that this invention is not limited to the precise arrangements shown in the figures and can be embodied in other arrangements without deviating from the scope of the invention.
  • Figure 1 is a block diagram of a mechanical ventilator and the control apparatus according to an alternative embodiment of the invention.
  • Figures 2a-2c show the flow chart of a software algorithm that also incorporates the control technique described in US Patent No. 4,986,268, to automatically control breathing frequency, tidal volume, and the adjustment in the I:E ratio of the patient on the ventilator, according to a preferred method of the present invention.
  • Figures 3a-3i show the flow chart of a software algorithm to automatically control PEEP (or CPAP) and F ⁇ o 2 according to a preferred method of the present invention.
  • Figures 4a-c show a preferred detailed schematic diagram of a Signal Generator and an Alarm Circuit, for use in a preferred practice of the present invention.
  • ventilator refers to a device which is used to provide total or assist ventilatory treatment to patients, and includes mechanical ventilators (i.e. artificial respirators) or CPAP (Continuous Positive Airway Pressure) machines.
  • mechanical ventilators i.e. artificial respirators
  • CPAP Continuous Positive Airway Pressure
  • PEEP represents “Positive End-Expiratory Pressure” and is interchangeable with the term “CPAP,” which represents “Continuous Positive Airway Pressure,” for example, when assist ventilation is provided to spontaneously breathing subjects.
  • F 102 represents "concentration of oxygen in a patient's inspiratory gas" which is the same as “fraction of inspired oxygen.”
  • I:E represents the "ratio of inspiration time to expiration time.”
  • FIG. 1 shows a block diagram according to an alternative practice of the present invention.
  • the digital processor 10 includes a programmable controller coupled to receive the outputs of 8 bit A/D converters 12, 14 and 16 as shown.
  • the A/D converters 18 and 20 are each a single 8 bit A/D converter.
  • the A/D converter unit 22 is an A/D board containing three 8 bit A/D converters.
  • the inputs 24, 26, and 28 of the A/Ds are from an oxygen sensor, preferably a pulse oximeter, 30, a CO 2 sensor, such as a transcutaneous monitor or preferably a capnograph, 32, and a lung mechanics calculator and PV monitor, 34.
  • the outputs 24, and 26 are each a single analog signal while the output 28 represents 3 analog signals; 1- representing respiratory elastance, 2- representing respiratory airway resistance (air viscosity factor in the lungs), and 3- representing the lower inflection point on the inspiratory or expiratory PV curve of the patient, or alternatively, the measured intrinsic PEEP (PEEPi) of the patient on the ventilator.
  • the inputs to the oxygen sensor and the carbon dioxide sensor are respectively shown at 40 and 42 coming from the patient.
  • the input 40 is preferably the arterial hemoglobin oxygen saturation data and the input to the CO sensor shown at 42 is preferably the exhaled gas from the patient from which the end-tidal CO 2 concentration or the end-tidal partial pressure of CO 2 is determined by the sensor.
  • the lung mechanics calculator and PV monitor, 34 receives data from the mechanical ventilator shown at 56, or from the patient through the ventilator circuit, on the line illustrated at 36 and communicates back to the ventilator as shown at 38.
  • the digital processor's outputs shown at 44 are applied to a Signal Generator Circuit, illustrated at 46.
  • the Signal Generator Circuit sends alarm instruction signals 52 to the alarm circuit 54.
  • the mechanical ventilator 56 receives the control signals 48 from the Signal Generator Circuit 46. These consist of signals to control PEEP, breathing frequency, tidal volume, and the adjustment in the I:E ratio of the patient.
  • a Mixer Regulator circuit 58 receives control signals to adjust F ⁇ , 50, from the Signal Generator Circuit 46.
  • An oxygen air mixer 62 receives the adjusted output signal 60 from the Mixer Regulator 58. The concentration of oxygen in the mixer is thereby adjusted by mixing the determined concentration of oxygen 66 coming from the oxygen supply 70 and that of air 64 coming from the air compressor 68.
  • the enriched oxygenated air 72 from the mixer is provided to the ventilator 56 which delivers it to the patient at 74.
  • FIG. 2a-2c there is illustrated a flow chart of the algorithm to control the breathing frequency, ventilation, and the adjustment in the E ratio in an alternative embodiment of the invention.
  • the initial values of breathing frequency and tidal volume are transmitted to the output ports in step 100.
  • the main loop at A is started and in the next step at 102, based on data indicative of CO and O 2 levels of the patient which are preferably provided by a capnograph and a pulse oximeter respectively, the arterial partial pressures of CO and O 2 are calculated by using the following equations:
  • P a co2 and P a o 2 are arterial partial pressures of CO 2 and O 2 respectively
  • P et co 2 is the end-tidal partial pressure of CO 2 measured by the CO 2 sensor
  • Ki is the difference between the arterial partial pressure of CO 2 and the end-tidal partial pressure of CO 2 .
  • K] can be measured in advance and depending on the patient's conditions, it can be adjusted to set the desired P a co 2 of the patient.
  • S p o 2 is the arterial hemoglobin oxygen saturation of the patient measured by a pulse oximeter and CP is an added correction factor which is used to correct and shift P a o 2 based on the patient's measured blood pH level.
  • CP is set to zero. Otherwise, CP needs to be adjusted by +3.5 mm Hg per every -0.1 deviation in pH from the above range.
  • P a co2 and P a o 2 their values are compared to defined minimum acceptable levels to determine whether there has been any measurement artifact in step 104. If any artifact is detected, the calculated value is discarded and the previous calculated value is resumed. In the next step at 106, if P a co 2 and/or P a o 2 are not within certain defined ranges, alarms are transmitted to the output ports.
  • step 108 if the calculated P a co 2 and P a o 2 values are both lower than their minimum threshold limits (which are different from the minimum acceptable values used in step 104), the possibility of pulmonary embolism is assumed, predefined levels of ventilation and breathing frequency are provided, and an alarm is generated in steps 110 and 112, and the program returns to A. However, if the calculated P a co2 and P a o 2 values are not found to be simultaneously lower than their minimum threshold levels in 108, then the effect of CO 2 on the required ventilation is calculated in step 114:
  • Vc is the ratio of alveolar ventilation as the net effect of CO 2 to the resting value of ventilation
  • step 116 the P a o 2 value is compared to a high threshold limit of 104 mm Hg. If P a o 2 is greater than or equal to this threshold value, the effect of oxygen on ventilation is set to zero in 118, and the next step at 122 is followed. Otherwise, if P a o 2 is found to be less than the threshold value in step 116, then control is passed to step 120 in which the effect of oxygen on the required ventilation is calculated by using the following equation:
  • Vo is the ratio of alveolar ventilation as the net effect of oxygen to the resting value of ventilation. It is recognized that the above equations are based on the use of a capnograph and a pulse oximeter to measure the carbon dioxide and oxygen levels of the patient respectively. If other measurement techniques are utilized to provide data indicative of said levels, then other alternative equations may be used to determine the required ventilation for the patient, without deviating from the scope and the essential attributes of the invention.
  • V M 0.988(MRR - 1)
  • V M is the ratio of alveolar ventilation as the net effect of increase in the metabolic rate ratio, MRR, to the resting value of ventilation, and MRR is an input to the algorithm.
  • MRR is the ratio of alveolar ventilation as the net effect of increase in the metabolic rate ratio, MRR, to the resting value of ventilation
  • MRR is an input to the algorithm.
  • V A is alveolar ventilation in liters/minute and V A at rest is the alveolar ventilation at rest which is input and stored in the software .
  • the physiological dead space of the patient, and the total dead space including that of the equipment are calculated, if not provided in advance, as follows:
  • V D (0.1698V A /60) + 0.1587
  • Vot V D + V ED
  • V D is the patient's dead space in liters
  • V ED is the equipment dead space due to the tubes and connections
  • Vo t is the total dead space.
  • the constant factors in these equations are based on measured experimental values for adults and can therefore be different for individual patients. Also, for other patient populations, they need to be adjusted. For example the constant factor of 0.1587 should change to a much smaller value for infants (e. g., 2.28x10 " ).
  • data indicative of barometric pressure and the patient's airway resistance (or the air viscosity factor in the lungs) and respiratory elastance are read from the input ports.
  • the barometric pressure data which is affected mostly by the altitude, is used as a reference pressure (for the purpose of calibration) in the invention.
  • the optimal frequency for the next breath is computed. This calculation is based on minimization of the respiratory work rate and is done in order to stimulate natural breathing, provide a more comfortable breathing pattern to the patient, and thereby, expedite the weaning process in assisted ventilation.
  • V A R is the alveolar ventilation in liters/second and is equal to V A /60
  • K' is the respiratory elastance (reciprocal of respiratory compliance) in cm H 2 O/liter
  • K" is the airway resistance in cm H 2 O/liter/second.
  • V ⁇ V A /60f + V Dt [0029]
  • V E represents total minute ventilation in liters/minute
  • VT is tidal volume in liters.
  • additional safety rules are applied. If breathing frequency, f, tidal volume, Vr, or minute ventilation are not within prescribed safe ranges, their values are limited and adjusted.
  • the breathing frequency is compared with an upper limit value F max .
  • T is the respiratory time constant and is equal to K'7 K'. If in step 136, the breathing frequency is found to be higher than F max , then in the next step at 138, its value is reduced to F ma ⁇ (in which case Vr is also adjusted according to procedures in steps 132 and 134), and step 140 is followed. Otherwise, if the computed breathing frequency is less than or equal to F max , it does not need further adjustment and the program is transferred to step 140. In step 140, the expiration time, T E , is compared to 2.5 times ⁇ .
  • step 142 is followed and the I:E ratio (the ratio of the inspiratory time to the expiratory time) is adjusted, so that T E becomes at least equal to 2.5 T. Otherwise, if T E is found to be greater than or equal to 2.5 T in step 140, it does not need to be adjusted (i.e. the adjustment value is zero) and the program is transferred to step 144.
  • the reason for the adjustments in the breathing frequency and T E in steps 138 and 142 mentioned above, is to provide sufficient time for exhalation based on the patient's respiratory time constant and to avoid build up of intrinsic positive end-expiratory pressure (PEEPi).
  • PEEPi intrinsic positive end-expiratory pressure
  • step 144 the calculated values for ventilation, breathing frequency, and the adjustment in the I:E ratio for the next breath are provided to the output ports.
  • the inspiratory pressure is calculated by using the following equation:
  • P m K'V ⁇ + PEEP where P m is the inspiratory pressure in cm H 2 O.
  • the control data indicative of P m is also provided to an output port and the routine is held for the duration of the next breathing cycle. After the delay is passed, the program returns to the beginning of the loop at A.
  • FIG. 3a-3i there is illustrated a flow chart of a control algorithm which is operated upon by the digital processor.
  • This algorithm is either run by itself, or in an alternative embodiment of the invention, it is run in parallel to the algorithm of Figures 2a-2c described above.
  • the purpose of this algorithm is to automatically control the levels of F102 and PEEP provided to the patient on the ventilator and thereby improve the patient's oxygenation.
  • the method depicted in Figures 3a-3i can be used for patients on mechanical ventilation or those on respiratory assist devices receiving CPAP treatment.
  • the term PEEP in the flow chart is meant to be interchangeable with CPAP.
  • step 200 the desired set point for arterial partial pressure of oxygen of the patient is defined in step 200. This is done on the basis of the patient's conditions and his/her underlying illness. Then in the next step at 202, the initial value of F I02 is set and transmitted to the output port.
  • the initial value of PEEP is set and transmitted to an output port.
  • the initial value of PEEP can be set by using different options. For certain patient groups such as COPD patients, the initial PEEP can be chosen to be 80% to 85% of the intrinsic PEEP (PEEPi) which needs to be measured in advance. For some other patient groups such as ARDS patients, the initial PEEP setting can be chosen to be 3-4 cm H 2 O above the lower inflection pressure point of the inspiratory (or the expiratory) pressure volume curve of the patient. This value can either be calculated by the lung mechanics calculator and PV monitor unit and provided automatically to the digital processor via an input port, or the calculated value of the pressure can be provided manually by the clinician either through one of the input ports or via software.
  • the third option is that the clinician arbitrarily decides an initial setting for PEEP and provides it to the digital processor, preferably via software.
  • the next step in 206 is followed.
  • a time parameter e.g., TP
  • the purpose of defining this parameter is to guarantee that PEEP adjustments are done only after a certain time has elapsed since the latest adjustment, thereby giving enough time to an adjustment in PEEP to make an impact on the patient's oxygenation.
  • step 208 which follows next, another parameter, AP, for PEEP adjustment is defined. If this parameter is set to zero, then PEEP is controlled manually and only F1 0 2 is automatically adjusted. If AP is set to one, then both F ⁇ )2 and PEEP are automatically controlled.
  • the threshold values for arterial hemoglobin oxygen saturation, S p o 2 are defined. In a preferred practice of the invention, four threshold values are defined for S p o 2 and they are set at 90%, 93%, 95%, and 97% respectively. However, the threshold values may differ for different patients. They should be defined based on the patient's conditions and the desired levels of oxygenation.
  • program control passes to step 212 in which a loop indicator (e.g., LI) is defined and is set to 1.5, and the main loop starts at A'.
  • a loop indicator e.g., LI
  • step 214 the patient's S p o2 data is read from one of the input ports, and in step 216, the arterial partial pressure of oxygen is calculated from the S- P0 2 data as:
  • P a o 2 is the arterial partial pressure of oxygen
  • CP is an added correction factor which is used to shift P a o 2 based on the patient's measured blood pH level. If the patient's blood pH is within 7.45-7.55, then CP is set to zero. Otherwise, for every +0.1 deviation in pH from this range, CP is adjusted by -3.5 mm Hg as was also mentioned in the description of Figure 2 earlier.
  • step 218 the calculated partial pressure of oxygen, P- a o 2 , is compared with a minimum acceptable value. This is done to detect artifacts in the measurement of S p o 2 - If the calculated P a o 2 is found to be less than the minimum acceptable value, then control passes to step 220 in which an artifact is assumed and an alarm is generated. Then step 222 is performed in which the S p o2 data is discarded and the previous value of P a o 2 in the memory is resumed and step 224 is followed. However, if in 218, the calculated P a o 2 is found to be greater than or equal to the minimum acceptable value, its value is accepted and control passes to step 224.
  • step 224 S p o 2 is compared to a minimum safe value, which is the first threshold value defined previously in step 210 (e.g., 90%). If S p o 2 is less than or equal to the minimum safe value, loop B is started in 226 and the loop indicator, LI, is set to 2.5. Then in step 228, F ⁇ o 2 is increased stepwise (i.e. in a step-like arrangement) to a high value, FI, (e.g., 60%), and an alarm is generated in 230. Control then passes to loop F at which the procedure of PEEP adjustment begins as will be described later.
  • a minimum safe value which is the first threshold value defined previously in step 210 (e.g. 90%). If S p o 2 is less than or equal to the minimum safe value, loop B is started in 226 and the loop indicator, LI, is set to 2.5. Then in step 228, F ⁇ o 2 is increased stepwise (i.e. in a step-like arrangement) to a high value, FI, (e.g.
  • a second threshold value e.g. 95%
  • step 232 if S p02 is found to be higher than or equal to the 2 nd threshold value (e. g., 93%), then steps 242 and 244 are followed in which LI is compared to 2. If it is less than 2, control passes to loop E. Otherwise, in the next step at 246, LI is compared to 3. If less than 3, loop C is defined and started at 248, and LI is set to 3.5. Then in step 250, F 102 is set stepwise at a moderately high value, F2 (e.g., 45%), and control transfers to loop F in which the procedure of PEEP adjustment is followed. However, if in step 246, LI is found to be greater than or equal to 3, control passes to step 252 in which LI is compared to 4.
  • the 2 nd threshold value e. g., 93%)
  • S p o2 is compared to a third threshold value (e.g., 95%) in step 254. If S p o2 is less than the third threshold value, control passes to loop C in which F ⁇ ) 2 was set at a moderately high level, F2 (e.g., 45%). Otherwise, if S p o2 is found to be higher than or equal to the third threshold value in 254, then the next step in 256 is followed in which loop D is defined and started and LI is set to 4.5. Next in step 258, F 102 is set stepwise at a slightly high level, F3 (e.g., 30%), and control passes to loop F.
  • a third threshold value e.g., 95%
  • step 252 if LI is found to be greater than or equal to 4, then S p o 2 is compared to a 4 th threshold value (e.g., 97%) in step 260. If S p o2 is less than the 4 th threshold value, control passes to loop D in which F102 was set at a slightly high value, F3 (e.g., 30%). Otherwise, if S p o 2 is higher than or equal to the 4 th threshold value in 260, then loop E is started in 262 and LI is set to 1.5. In loop E, a proportional, integral, derivative (PID) control procedure is performed to adjust F10 2 (PID control is a control technique comprising proportional, integral, and derivative terms). In the next step at 264, using the P a o 2 set point defined in step 200, the proportional, differential, and integral components of error are calculated as follows:
  • Y ⁇ (k), Y 2 (k), and Y 3 (k) represent the proportional, differential, and integral components of error in P a o 2 respectively, and T is a sampling interval.
  • E(k) is an error function
  • ⁇ , and ⁇ are the PID coefficients
  • G(k) is the required F 102 -
  • T is set to 0.75 seconds
  • a, ⁇ , and ⁇ are set to 6.45xl0 "5 , 3.22xl0 "5 , and 7.29xl0 "6 respectively.
  • step 270 the calculated value of F10 2 is compared with a minimum of 0.21 (i.e. 21%). If the F 102 value is less than 21%, in step 270 which follows, it is set to a minimum of 21% and control passes to loop F. However, if in 268, F 102 is found to be greater than or equal to 21%, control passes to step 272 in which F102 is compared to a maximum allowed value (e.g., 80%). If F ⁇ ) 2 is less than or equal to the maximum allowed value, the next step in 274 is followed where the calculated value of F K ⁇ is sent to the output port and control passes to step 276. In this step F > 2 is compared to 60%.
  • a maximum allowed value e.g., 80%
  • the controller switches from the PID control to the rapid stepwise algorithm only if rapid declines in S p o 2 are detected.
  • the controller continuously checks S p o2, and if it rises, the controller reduces F 102 to minimize the exposure of the patient to high and toxic levels of F ⁇ o 2 -
  • the controller is designed to correct hypoxemia within seconds and to avoid hyperoxemia. As shown, the controller detects artifacts in the measurement of S p o 2 , discards the artifacts, and generates alarms when appropriate.
  • the algorithm also enables clinicians to define the desired oxygenation levels for different patients. This is done by defining an appropriate P a o2 set point, by setting the threshold values for S p o 2 , and by adjusting the correction parameter, CP, in accordance with the measured pH levels in the patient's blood as described above.
  • the procedure of adjusting the PEEP value is started at F in step 282.
  • the ratio of PEEP/F102 is calculated.
  • the control parameter AP which was defined in step 208, is examined. If it is less than 1, it means that PEEP is not adjusted automatically and it is instead adjusted manually by the operator. In this case, the controller merely watches the PEEP/F1 02 ratio and generates warning signals, if the ratio is either too low or too high.
  • the ratio is compared to a minimum allowed value (e.g., 0.12). If it is less than the minimum value, an alarm is generated in 288 and control passes to I (which will be described later).
  • step 286 if the PEEP/Frc ⁇ ratio is found to be equal to or greater than the minimum value in step 286, then the next step in 290 is performed where the ratio is compared to a maximum allowed value (e.g., 0.22). If the ratio is less than or equal to the maximum value, control passes to I. Otherwise, an alarm is generated in step 292 and then control is transferred to I.
  • a maximum allowed value e.g. 0.25
  • step 284 if AP is not less than 1, it means that PEEP should be calculated and automatically adjusted. Therefore, the automatic PEEP adjustment control loop is started next at G at step 294.
  • the PEEP/F- !02 ratio is compared to a minimum allowed value (e.g., 0.12). If it is less than the minimum, the procedure at H is started and it is examined how long ago the last adjustment in PEEP was made.
  • the time parameter, TP is compared to a defined fixed interval, Tl, for example 240 seconds. If TP is less than 240 seconds, it means that the last PEEP adjustment was made less than 4 minutes ago. Then the procedure at J is started. Control passes to step 302 in which no change is made in PEEP and the time parameter, TP, is increased by a fixed amount (e.g., 0.75 seconds):
  • a fixed amount e.g., 2 cm H 2 O
  • step 308 if the PEEP/F I02 ratio is not found to be less than the minimum allowed value, control transfers to step 308.
  • the routine is held for a fixed interval (e.g., 0.75 seconds) and then control returns to the beginning of the main loop at A'.
  • step 320 is next followed.
  • S p o 2 is compared to a predefined minimum allowed value (e.g., 92%). If it is higher than or at least equal to the predefined minimum value, the PEEP level is not changed and control passes to J. However, if in 320, S p o 2 is found to be less than the predefined minimum value, then control passes to H, where it is determined whether at least 4 minutes have passed since the last PEEP adjustment, and if so, PEEP is increased by a fixed amount (e. g., 2 cm H 2 O) as was shown earlier.
  • a fixed amount e. g., 2 cm H 2 O
  • the PEEP/F102 is kept within a clinically acceptable range. As shown above, if the PEEP/F1 0 2 is too low, PEEP is increased by a fixed increment (e.g., 2 cm H 2 O). Also, if the PEEP/F1 0 2 ratio is within the acceptable range and S p o 2 is low, then PEEP is increased by a fixed increment (e.g., 2 cm H 2 O) to improve patient's oxygenation. On the other hand, if the PEEP/F ⁇ o 2 ratio increases beyond a maximum defined value, the program reduces PEEP in fixed amounts (e.g., 2 cm H 2 O). In any case, the interval between two successive PEEP adjustments is at least equal to a fixed period (e.g., 240 seconds), to allow for the changes in PEEP to have an observable and measurable impact on the patient's oxygenation.
  • a fixed period e.g., 240 seconds
  • Figures 4a-c illustrate in detail, a preferred circuit diagram of the Signal Generator Circuit, 46, and the alarm circuit 54.
  • the preferred component types and values are shown in the chart below:
  • the invention utilizes data indicative of measured oxygen levels of the patient to automatically control F1 0 2, and PEEP (or CPAP).
  • the invention further uses the respiratory mechanics data (i.e. respiratory elastance and airway resistance) to automatically make the necessary adjustments in the I:E ratio of the patient on the ventilator.
  • It further incorporates the features of US Patent No. 4,986,268 and uses data indicative of measured levels of oxygen and the respiratory mechanics data of the patient, along with data indicative of barometric pressure (as a reference calibrating pressure), and data indicative of measured carbon dioxide level of the patient to automatically control the breathing frequency and tidal volume of breaths of the patient on the ventilator.
  • the invention also detects and corrects artifacts in the measured oxygen and carbon dioxide data and applies safety rules.
  • the invention can improve total and/or assist ventilatory treatments provided to different patient groups.

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

Method and apparatus for controlling a ventilator are described. The invention can be used to control mechanical ventilators (56) as well as respiratory assist devices such as CPAP machines. The apparatus receives input data indicative of patient's oxygen level. A controller (10) determines PEEP, or CPAP, and FIO2, on the basis of data indicative of the patient's oxygen level. In an alternative embodiment, the apparatus further receives input data indicative of patient's carbon dioxide levels, respiratory elastance and airway resistance, and barometric pressure. The controller further utilizes the said input data to determine the optimal values of tidal volume and breathing frequency for a next breath of the patient, and uses the respiratory elastance and airway resistance data to determine any necessary adjustments in the I:E ratio. The controller also applies safety rules, detects and corrects artifacts, and generates warning signals when needed.

Description

METHOD AND APPARATUS FOR CONTROLLING A VENTI TOR
Cross Reference to Related Applications
This application claims the benefit of U.S. provisional patent application number 60/481,693, filed November 21, 2003, and U.S. patent application number 10/935,446, filed September 7, 2004, the entire contentsof each of which are incorporated herein by reference. This application is related to US Patent No. 4,986,268 entitled "Method and Apparatus for Controlling an Artificial Respirator," the disclosure of which is incorporated by reference.
Background of Invention
[0001 ] FIELD OF THE INVENTION
The present invention relates to a method and apparatus for controlling a ventilator such as a mechanical ventilator (i.e. an artificial respirator) or a respiratory assist device. In particular, the present invention relates to a method and apparatus for controlling a ventilator based on the measured levels of oxygen of the patient on the ventilator, as well as other physical conditions of the patient.
[0002] BACKGROUND OF THE INVENTION Mechanical ventilators and other respiratory assist devices are extensively used to treat and manage all patient populations. In the past few decades, there have been significant changes in the features offered by the ventilators and they have become increasingly responsive to individual patient needs. However, despite much advancement in these devices, most ventilators used today are still mainly open-loop controlled devices and their added features have to some extent contributed to their complexity. The clinicians are required to make many important selections among the wide range of options available in advanced mechanical ventilators. Optimal adjustment of these machines oftentimes requires in depth knowledge about the ventilator along- with thorough review of the patient's status and his/her underlying illness. These adjustments are particularly cumbersome and frequent in more fragile and less medically stable patients.
[0003] There have been many attempts in the past to automatically control some of the main outputs of mechanical ventilators. See Y. Mitamura et al., "A dual control system for assisting respiration," Medical and Biological Engineering, vol. 13, no. 6, pages 846-854, 1975, Yu et al., "Improvement in arterial oxygen control using multiple model adaptive control procedures," IEEE Transactions on Biomedical Engineering, BME-34(8), pages 567-574, 1987, and US Patent No. 4,986,268 to F. T. Tehrani, issued January 22, 1991, entitled "Method and apparatus for controlling an artificial respirator."
[0004] Also, see US Patent No. 5,103,814 to T. Maher, issued April 14, 1992, entitled "Self-compensating patient respirator," Morozoff P. E., and Evans R. W., "Closed- loop control of Sao2 in the neonate," Biomedical Instrumentation and Technology, vol. 26, pages 117-123, 1992, US Patent No. 5,365,922 to D. B. Raemer issued November 22, 1994 entitled "Closed-loop non-invasive oxygen saturation control system," Tehrani et al. "Closed-loop control of the inspired fraction of oxygen in mechanical ventilation," Journal of Clinical Monitoring and Computing, vol. 17, No. 6, pages 367-376, 2002, and US Patent No. 6,671,529 to N. R. Claure et al., issued December 30, 2003, entitled "System and method for closed-loop controlled inspired oxygen concentration."
[0005] Some of the prior art on this subject is focused on controlling the patient's oxygenation, and some is intended to automatically control the breathing frequency and tidal volume. The systems intended for controlling only the oxygen level of the patient on the ventilator, either do not provide the automation of all factors that affect oxygenation and/or they do not provide a reliable and sufficiently robust response against oxygen disturbances.
[0006] In addition to advancement in mechanical ventilators, there have been many attempts in recent years to prevent the collapse of the airways and apnea in spontaneously breathing patients specially during sleep, by using less elaborate machines than mechanical ventilators, generally known as CPAP machines (CPAP stands for Continuous Positive Airway Pressure). In these machines, either a constant pressure is applied to the patient's airways throughout respiration (i.e. CPAP), or a combination of CPAP and pressure support in inspiration is used to ventilate the patient (e.g. bilevel CPAP machines). See US Patent No. 4,773,411 to J. B. Downs issued September 27, 1988, entitled "Method and apparatus for ventilatory therapy," International Patent Publication No. WO 99/61088 to Resmed Limited, issued December 2, 1999, entitled "Ventilatory assistance for treatment of cardiac failure and Cheyne-Stokes breathing," US Patent No. 6,539,940 to R. J. Zdrojkowski et al., issued April 1, 2003, entitled "Breathing gas delivery method and apparatus," and US Patent No. 6,752,151 to P. D. Hill, issued June 22, 2004, entitled "Method and apparatus for providing variable positive airway pressure."
[0007] In one embodiment, the present invention describes a method and apparatus that can reliably and robustly control PEEP (or CPAP), and Fto2. These are novel features which significantly improve the oxygenation of patients during ventilatory therapy provided by mechanical ventilators as well as respiratory devices such as CPAP machines.
[0008] Furthermore, in a more elaborate embodiment of the invention, in addition to PEEP (or CPAP) and F102, the I:E ratio of the patient can be automatically adjusted and by further inclusion of the features of US Patent No. 4,986,268, the breathing frequency, and tidal volume can be automatically controlled in mechanical ventilation. Application of these features results in a significantly more effective and optimal treatment to the patient based on his/her conditions and requirements, in total or assist ventilatory therapy.
Summary of Invention
[0009] A method and apparatus for controlling a ventilator includes first means receiving at least input data indicative of the patient's measured oxygen levels, and in a more elaborate embodiment of the invention, the first means also receives respiratory mechanics and/or pressure- volume data, as well as data indicative of measured carbon dioxide levels of the patient. The first means which preferably comprises a programmable microprocessor, is controlled by a software algorithm to operate on the input data, and to provide digital output data to control the ventilator and the gas mixer of the ventilator. The software algorithm is divided into two control programs. One control program which can either be used by itself or along with the other program, is designed to automatically adjust Fκ)2 and PEEP (or CPAP), based on at least the measured oxygen levels of the patient. The control program also operates on data from a pressure volume (PV) monitor/analyzer to set the initial PEEP value in certain groups of respiratory patients. The processing means detects hazardous conditions based on the input data and/or artifacts, replaces and/or corrects the measurement artifacts, and instructs generation of appropriate warning signals. The other control program, most of which is described in US Patent No. 4,986,268, is designed to control the frequency and ventilation for a next breath of the patient on the ventilator based on at least data indicative of measured CO2 and O2 levels of the patient, barometric pressure (as a reference pressure), and respiratory elastance and airway resistance (respiratory mechanics) data; and to make necessary adjustments in the I:E ratio based on the patient's respiratory mechanics data. The output data from the 1st means indicative of PEEP (or CPAP), F102, the adjustment in the I:E ratio, breathing frequency, and ventilation, and status of alarms are transmitted to a Signal Generator which is equipped with converters and/or other electronic components to generate the control and appropriate warning signals. The control signals for the breathing frequency, ventilation, PEEP (or CPAP), and the adjustment in the I:E ratio are supplied to the ventilator. The control signal for Fκ)2 is supplied to a mixer regulator unit which adjusts the concentration of oxygen added to the inhalation gas in the gas mixer of the ventilator. Based on the instructions from the 1st means, the alarm circuit generates appropriate warning signals when needed.
Brief Description of Drawings
[0010] Figures 1-4 illustrate a preferred embodiment of the present invention. However, it is understood that this invention is not limited to the precise arrangements shown in the figures and can be embodied in other arrangements without deviating from the scope of the invention.
[0011 ] Figure 1 is a block diagram of a mechanical ventilator and the control apparatus according to an alternative embodiment of the invention.
[0012] Figures 2a-2c show the flow chart of a software algorithm that also incorporates the control technique described in US Patent No. 4,986,268, to automatically control breathing frequency, tidal volume, and the adjustment in the I:E ratio of the patient on the ventilator, according to a preferred method of the present invention.
[0013] Figures 3a-3i show the flow chart of a software algorithm to automatically control PEEP (or CPAP) and Fτo2 according to a preferred method of the present invention. [0014] Figures 4a-c show a preferred detailed schematic diagram of a Signal Generator and an Alarm Circuit, for use in a preferred practice of the present invention.
Detailed Description
Definitions
[0015] In the specification and claims:
1- The term "ventilator" refers to a device which is used to provide total or assist ventilatory treatment to patients, and includes mechanical ventilators (i.e. artificial respirators) or CPAP (Continuous Positive Airway Pressure) machines.
2- The term "PEEP" represents "Positive End-Expiratory Pressure" and is interchangeable with the term "CPAP," which represents "Continuous Positive Airway Pressure," for example, when assist ventilation is provided to spontaneously breathing subjects.
3- The term "F102" represents "concentration of oxygen in a patient's inspiratory gas" which is the same as "fraction of inspired oxygen."
4- The term I:E represents the "ratio of inspiration time to expiration time."
Description of Preferred Embodiments
[0016] Figure 1 shows a block diagram according to an alternative practice of the present invention. The digital processor 10 includes a programmable controller coupled to receive the outputs of 8 bit A/D converters 12, 14 and 16 as shown. The A/D converters 18 and 20 are each a single 8 bit A/D converter. The A/D converter unit 22 is an A/D board containing three 8 bit A/D converters. The inputs 24, 26, and 28 of the A/Ds are from an oxygen sensor, preferably a pulse oximeter, 30, a CO2 sensor, such as a transcutaneous monitor or preferably a capnograph, 32, and a lung mechanics calculator and PV monitor, 34. The outputs 24, and 26 are each a single analog signal while the output 28 represents 3 analog signals; 1- representing respiratory elastance, 2- representing respiratory airway resistance (air viscosity factor in the lungs), and 3- representing the lower inflection point on the inspiratory or expiratory PV curve of the patient, or alternatively, the measured intrinsic PEEP (PEEPi) of the patient on the ventilator. The inputs to the oxygen sensor and the carbon dioxide sensor are respectively shown at 40 and 42 coming from the patient. The input 40 is preferably the arterial hemoglobin oxygen saturation data and the input to the CO sensor shown at 42 is preferably the exhaled gas from the patient from which the end-tidal CO2 concentration or the end-tidal partial pressure of CO2 is determined by the sensor. The lung mechanics calculator and PV monitor, 34, receives data from the mechanical ventilator shown at 56, or from the patient through the ventilator circuit, on the line illustrated at 36 and communicates back to the ventilator as shown at 38. The digital processor's outputs shown at 44 are applied to a Signal Generator Circuit, illustrated at 46. The Signal Generator Circuit sends alarm instruction signals 52 to the alarm circuit 54.
[0017] The mechanical ventilator 56 receives the control signals 48 from the Signal Generator Circuit 46. These consist of signals to control PEEP, breathing frequency, tidal volume, and the adjustment in the I:E ratio of the patient. A Mixer Regulator circuit 58, receives control signals to adjust F ^, 50, from the Signal Generator Circuit 46. An oxygen air mixer 62 receives the adjusted output signal 60 from the Mixer Regulator 58. The concentration of oxygen in the mixer is thereby adjusted by mixing the determined concentration of oxygen 66 coming from the oxygen supply 70 and that of air 64 coming from the air compressor 68. The enriched oxygenated air 72 from the mixer is provided to the ventilator 56 which delivers it to the patient at 74. [0018] Referring to Figure 2a-2c, there is illustrated a flow chart of the algorithm to control the breathing frequency, ventilation, and the adjustment in the E ratio in an alternative embodiment of the invention. As seen at the start of the flow chart, the initial values of breathing frequency and tidal volume are transmitted to the output ports in step 100. Then the main loop at A is started and in the next step at 102, based on data indicative of CO and O2 levels of the patient which are preferably provided by a capnograph and a pulse oximeter respectively, the arterial partial pressures of CO and O2 are calculated by using the following equations:
PaC02 = PetCθ2 + Ki
Figure imgf000009_0001
[0019] Where Paco2 and Pao2 are arterial partial pressures of CO2 and O2 respectively, Petco2 is the end-tidal partial pressure of CO2 measured by the CO2 sensor, and Ki is the difference between the arterial partial pressure of CO2 and the end-tidal partial pressure of CO2. K] can be measured in advance and depending on the patient's conditions, it can be adjusted to set the desired Paco2 of the patient. Spo2 is the arterial hemoglobin oxygen saturation of the patient measured by a pulse oximeter and CP is an added correction factor which is used to correct and shift Pao2 based on the patient's measured blood pH level. If the patient's blood pH level is in the 7.45-7.55 range, CP is set to zero. Otherwise, CP needs to be adjusted by +3.5 mm Hg per every -0.1 deviation in pH from the above range. After the calculation of Paco2 and Pao2, their values are compared to defined minimum acceptable levels to determine whether there has been any measurement artifact in step 104. If any artifact is detected, the calculated value is discarded and the previous calculated value is resumed. In the next step at 106, if Paco2 and/or Pao2 are not within certain defined ranges, alarms are transmitted to the output ports. In the step that follows at 108, if the calculated Paco2 and Pao2 values are both lower than their minimum threshold limits (which are different from the minimum acceptable values used in step 104), the possibility of pulmonary embolism is assumed, predefined levels of ventilation and breathing frequency are provided, and an alarm is generated in steps 110 and 112, and the program returns to A. However, if the calculated Paco2 and Pao2 values are not found to be simultaneously lower than their minimum threshold levels in 108, then the effect of CO2 on the required ventilation is calculated in step 114:
Figure imgf000010_0001
[0020] Where Vc is the ratio of alveolar ventilation as the net effect of CO2 to the resting value of ventilation, Ci is the sensitivity factor of the controller to CO2 (e. g., Ci = 0.405) and C2 is a constant (e. g., C2 = 14.88).
[0021] Next, in step 116, the Pao2 value is compared to a high threshold limit of 104 mm Hg. If Pao2 is greater than or equal to this threshold value, the effect of oxygen on ventilation is set to zero in 118, and the next step at 122 is followed. Otherwise, if Pao2 is found to be less than the threshold value in step 116, then control is passed to step 120 in which the effect of oxygen on the required ventilation is calculated by using the following equation:
Vo = (4.72xl0-9)(104 - PaO2)49
[0022] Where Vo is the ratio of alveolar ventilation as the net effect of oxygen to the resting value of ventilation. It is recognized that the above equations are based on the use of a capnograph and a pulse oximeter to measure the carbon dioxide and oxygen levels of the patient respectively. If other measurement techniques are utilized to provide data indicative of said levels, then other alternative equations may be used to determine the required ventilation for the patient, without deviating from the scope and the essential attributes of the invention.
[0023] In the next step at 122, the effect of increase in the metabolic rate ratio, MRR, (i. e. rate of metabolism/basal rate of metabolism), on ventilation is calculated by using the following equation:
VM = 0.988(MRR - 1)
[0024] Where VM is the ratio of alveolar ventilation as the net effect of increase in the metabolic rate ratio, MRR, to the resting value of ventilation, and MRR is an input to the algorithm. In the next step at 124, total alveolar ventilation for the next breath is calculated: VA = (VA at rest)(Vc + Vo + VM)
[0025] Where VA is alveolar ventilation in liters/minute and VA at rest is the alveolar ventilation at rest which is input and stored in the software . In the next step at 126, the physiological dead space of the patient, and the total dead space including that of the equipment are calculated, if not provided in advance, as follows:
VD = (0.1698VA/60) + 0.1587
Vot = VD + VED
[0026] In these equations, VD is the patient's dead space in liters, VED is the equipment dead space due to the tubes and connections, and Vot is the total dead space. It should be noted that the constant factors in these equations are based on measured experimental values for adults and can therefore be different for individual patients. Also, for other patient populations, they need to be adjusted. For example the constant factor of 0.1587 should change to a much smaller value for infants (e. g., 2.28x10" ). In the next step at 128, data indicative of barometric pressure and the patient's airway resistance (or the air viscosity factor in the lungs) and respiratory elastance are read from the input ports. The barometric pressure data which is affected mostly by the altitude, is used as a reference pressure (for the purpose of calibration) in the invention.
[0027] In the next step at 130, the optimal frequency for the next breath is computed. This calculation is based on minimization of the respiratory work rate and is done in order to stimulate natural breathing, provide a more comfortable breathing pattern to the patient, and thereby, expedite the weaning process in assisted ventilation. The following equation, which is a modified version of an equation derived in 1950 by Otis et al. to describe the control of breathing frequency in mammals, is used to calculate the optimal breathing frequency in the invention:
-κ'vD +. (κ'vD)2 + 4K'K"Π2VAR D f= 2κ rrvD
[0028] where f is the optimum breathing frequency in breaths/second, VAR is the alveolar ventilation in liters/second and is equal to VA/60, K' is the respiratory elastance (reciprocal of respiratory compliance) in cm H2O/liter and K" is the airway resistance in cm H2O/liter/second. Next in step 132, the required minute ventilation and tidal volume are calculated: VE = VA + όOfVot
Vτ = VA/60f + VDt [0029] Where VE represents total minute ventilation in liters/minute and VT is tidal volume in liters. In the next step at 134, additional safety rules are applied. If breathing frequency, f, tidal volume, Vr, or minute ventilation are not within prescribed safe ranges, their values are limited and adjusted.
[0030] In the next step 136 which follows, the breathing frequency is compared with an upper limit value Fmax. This upper limit frequency is defined as: Fmax = l/5τ
[0031 ] Where T is the respiratory time constant and is equal to K'7 K'. If in step 136, the breathing frequency is found to be higher than Fmax, then in the next step at 138, its value is reduced to Fmaχ (in which case Vr is also adjusted according to procedures in steps 132 and 134), and step 140 is followed. Otherwise, if the computed breathing frequency is less than or equal to Fmax, it does not need further adjustment and the program is transferred to step 140. In step 140, the expiration time, TE, is compared to 2.5 times τ. If it is found to be less than 2.5 T, then step 142 is followed and the I:E ratio (the ratio of the inspiratory time to the expiratory time) is adjusted, so that TE becomes at least equal to 2.5 T. Otherwise, if TE is found to be greater than or equal to 2.5 T in step 140, it does not need to be adjusted (i.e. the adjustment value is zero) and the program is transferred to step 144. The reason for the adjustments in the breathing frequency and TE in steps 138 and 142 mentioned above, is to provide sufficient time for exhalation based on the patient's respiratory time constant and to avoid build up of intrinsic positive end-expiratory pressure (PEEPi).
[0032] In step 144 that follows, the calculated values for ventilation, breathing frequency, and the adjustment in the I:E ratio for the next breath are provided to the output ports. At this point, if the ventilator is in the pressure control/assist mode, the inspiratory pressure is calculated by using the following equation:
Pm = K'Vχ + PEEP where Pm is the inspiratory pressure in cm H2O. Thereafter, the control data indicative of Pm is also provided to an output port and the routine is held for the duration of the next breathing cycle. After the delay is passed, the program returns to the beginning of the loop at A.
[0033] It should be noted that the major portion of the procedure depicted in Figure 2 to calculate the optimal breathing frequency and tidal volume of the breaths of a patient and controlling them automatically, has been described in US Patent No. 4,986,268. In the present invention, the necessary adjustments in the I:E ratio are controlled automatically as described above, and the levels of F102 and PEEP are automatically controlled by another algorithm which is described next.
[0034] Referring to Figures 3a-3i, there is illustrated a flow chart of a control algorithm which is operated upon by the digital processor. This algorithm is either run by itself, or in an alternative embodiment of the invention, it is run in parallel to the algorithm of Figures 2a-2c described above. The purpose of this algorithm is to automatically control the levels of F102 and PEEP provided to the patient on the ventilator and thereby improve the patient's oxygenation. The method depicted in Figures 3a-3i can be used for patients on mechanical ventilation or those on respiratory assist devices receiving CPAP treatment. Depending on the type of the ventilatory treatment, the term PEEP in the flow chart is meant to be interchangeable with CPAP. [0035] As is seen, at the start of the flow chart, the desired set point for arterial partial pressure of oxygen of the patient is defined in step 200. This is done on the basis of the patient's conditions and his/her underlying illness. Then in the next step at 202, the initial value of FI02 is set and transmitted to the output port.
[0036] In step 204 that follows next, the initial value of PEEP is set and transmitted to an output port. The initial value of PEEP can be set by using different options. For certain patient groups such as COPD patients, the initial PEEP can be chosen to be 80% to 85% of the intrinsic PEEP (PEEPi) which needs to be measured in advance. For some other patient groups such as ARDS patients, the initial PEEP setting can be chosen to be 3-4 cm H2O above the lower inflection pressure point of the inspiratory (or the expiratory) pressure volume curve of the patient. This value can either be calculated by the lung mechanics calculator and PV monitor unit and provided automatically to the digital processor via an input port, or the calculated value of the pressure can be provided manually by the clinician either through one of the input ports or via software. The third option is that the clinician arbitrarily decides an initial setting for PEEP and provides it to the digital processor, preferably via software. After setting the initial PEEP value in 204, the next step in 206 is followed. At this point, a time parameter (e.g., TP) for PEEP adjustment is defined and initially set to zero. The purpose of defining this parameter is to guarantee that PEEP adjustments are done only after a certain time has elapsed since the latest adjustment, thereby giving enough time to an adjustment in PEEP to make an impact on the patient's oxygenation.
[0037] In step 208 which follows next, another parameter, AP, for PEEP adjustment is defined. If this parameter is set to zero, then PEEP is controlled manually and only F102 is automatically adjusted. If AP is set to one, then both Fκ)2 and PEEP are automatically controlled. [0038] In the next step 210, the threshold values for arterial hemoglobin oxygen saturation, Spo2, (or alternatively for arterial partial pressure of oxygen) are defined. In a preferred practice of the invention, four threshold values are defined for Spo2 and they are set at 90%, 93%, 95%, and 97% respectively. However, the threshold values may differ for different patients. They should be defined based on the patient's conditions and the desired levels of oxygenation.
[0039] Next, program control passes to step 212 in which a loop indicator (e.g., LI) is defined and is set to 1.5, and the main loop starts at A'.
[0040] In the next step in 214, the patient's Spo2 data is read from one of the input ports, and in step 216, the arterial partial pressure of oxygen is calculated from the S- P02 data as:
Figure imgf000016_0001
[0041] Where Pao2 is the arterial partial pressure of oxygen, and CP is an added correction factor which is used to shift Pao2 based on the patient's measured blood pH level. If the patient's blood pH is within 7.45-7.55, then CP is set to zero. Otherwise, for every +0.1 deviation in pH from this range, CP is adjusted by -3.5 mm Hg as was also mentioned in the description of Figure 2 earlier.
[0042] In step 218 that follows next, the calculated partial pressure of oxygen, P- ao2, is compared with a minimum acceptable value. This is done to detect artifacts in the measurement of Spo2- If the calculated Pao2 is found to be less than the minimum acceptable value, then control passes to step 220 in which an artifact is assumed and an alarm is generated. Then step 222 is performed in which the Spo2 data is discarded and the previous value of Pao2 in the memory is resumed and step 224 is followed. However, if in 218, the calculated Pao2 is found to be greater than or equal to the minimum acceptable value, its value is accepted and control passes to step 224.
[0043] In step 224, Spo2 is compared to a minimum safe value, which is the first threshold value defined previously in step 210 (e.g., 90%). If Spo2 is less than or equal to the minimum safe value, loop B is started in 226 and the loop indicator, LI, is set to 2.5. Then in step 228, Fτo2 is increased stepwise (i.e. in a step-like arrangement) to a high value, FI, (e.g., 60%), and an alarm is generated in 230. Control then passes to loop F at which the procedure of PEEP adjustment begins as will be described later. However, if Spo2 is found to be higher than the minimum safe value in step 224, control passes to 232 where Spo2 is compared to a second threshold value (e.g., 93%). If Spo2 is less than the second threshold value, then steps 234 and 236 are followed in which the loop indicator, LI, is examined and compared to 2. If LI is less than 2, control passes to another loop E which will be described later. If LI is greater than or equal to 2, the next step in 238 is performed in which LI is compared to 3. If LI is less than 3, control passes to loop B (where FI()2 was set high at FI, e.g., 60%), otherwise, the program transfers to step 240. In this step, LI is compared to 4. If it is less than 4, control passes to loop C; otherwise, the program transfers to loop D (loops C and D will be described later).
[0044] Back to step 232, if Sp02 is found to be higher than or equal to the 2nd threshold value (e. g., 93%), then steps 242 and 244 are followed in which LI is compared to 2. If it is less than 2, control passes to loop E. Otherwise, in the next step at 246, LI is compared to 3. If less than 3, loop C is defined and started at 248, and LI is set to 3.5. Then in step 250, F102 is set stepwise at a moderately high value, F2 (e.g., 45%), and control transfers to loop F in which the procedure of PEEP adjustment is followed. However, if in step 246, LI is found to be greater than or equal to 3, control passes to step 252 in which LI is compared to 4. If LI is less than 4, then Spo2 is compared to a third threshold value (e.g., 95%) in step 254. If Spo2 is less than the third threshold value, control passes to loop C in which Fκ)2 was set at a moderately high level, F2 (e.g., 45%). Otherwise, if Spo2 is found to be higher than or equal to the third threshold value in 254, then the next step in 256 is followed in which loop D is defined and started and LI is set to 4.5. Next in step 258, F102 is set stepwise at a slightly high level, F3 (e.g., 30%), and control passes to loop F.
[0045] Back to step 252, if LI is found to be greater than or equal to 4, then Spo2 is compared to a 4th threshold value (e.g., 97%) in step 260. If Spo2 is less than the 4th threshold value, control passes to loop D in which F102 was set at a slightly high value, F3 (e.g., 30%). Otherwise, if Spo2 is higher than or equal to the 4th threshold value in 260, then loop E is started in 262 and LI is set to 1.5. In loop E, a proportional, integral, derivative (PID) control procedure is performed to adjust F102 (PID control is a control technique comprising proportional, integral, and derivative terms). In the next step at 264, using the Pao2 set point defined in step 200, the proportional, differential, and integral components of error are calculated as follows:
Yι(k) = Pa02(set-point) - Pa02
Y2(k) = [Y1(k) - Y1(k -l)]/T
Figure imgf000018_0001
[0046] In the above equations, Yι(k), Y2(k), and Y3(k) represent the proportional, differential, and integral components of error in Pao2 respectively, and T is a sampling interval. [0047] In step 266 that follows, the required F102 is calculated by using the following equations: E(k) = αY,(k) +/3Y3(k) +γY2(k)
G(k) = E(k) + 0.21
[0048] Where E(k) is an error function, , β, and γ are the PID coefficients, and G(k) is the required F102- In a preferred practice of the invention, T is set to 0.75 seconds, and a, β, and γ are set to 6.45xl0"5, 3.22xl0"5, and 7.29xl0"6 respectively.
These parameters were tuned to minimize steady-state oscillations and to keep the overshoot/undershoot in the FJO2 response of the PID controller below 25% of the total change. It is also recognized that other error correction schemes can be used to determine Fιo2- As long as those schemes reduce the error in the oxygen level of the patient in a similar way as described above, they will be within the scope of the present invention.
[0049] In the next step in 268, the calculated value of F102 is compared with a minimum of 0.21 (i.e. 21%). If the F102 value is less than 21%, in step 270 which follows, it is set to a minimum of 21% and control passes to loop F. However, if in 268, F102 is found to be greater than or equal to 21%, control passes to step 272 in which F102 is compared to a maximum allowed value (e.g., 80%). If Fκ)2 is less than or equal to the maximum allowed value, the next step in 274 is followed where the calculated value of FK^ is sent to the output port and control passes to step 276. In this step F >2 is compared to 60%. If it is less than 60%, control passes to loop F. Otherwise, an alarm is generated in 278 and then control transfers to loop F. [0050] Back to step 272, if the calculated value of F102 is found to be higher than the maximum allowed value, it is reduced to the maximum value in step 280, an alarm is generated, and then control transfers to loop F.
[0051] Up to the beginning of loop F at step 282, the focus of control is on automatic control of Fκ>2- AS shown, two different mechanisms are incorporated in the control process of F102 in a preferred practice of the invention. One, a rapid stepwise control scheme which responds instantly to fast declines in Spo2, and the other, a more finely controlled PID algorithm that provides fine control of Fι02 in the absence of sharp and hazardous declines in Spo2- The stepwise controller in a preferred practice of the invention has three loops, each with its defined minimum and maximum Spo2 threshold levels. These three loops were shown respectively at B, C, and D, and the PID control loop was shown at E in the flow chart of Figure 3. The controller switches from the PID control to the rapid stepwise algorithm only if rapid declines in Spo2 are detected. Once in the stepwise mode, the controller continuously checks Spo2, and if it rises, the controller reduces F102 to minimize the exposure of the patient to high and toxic levels of Fιo2- The controller is designed to correct hypoxemia within seconds and to avoid hyperoxemia. As shown, the controller detects artifacts in the measurement of Spo2, discards the artifacts, and generates alarms when appropriate. The algorithm also enables clinicians to define the desired oxygenation levels for different patients. This is done by defining an appropriate Pao2 set point, by setting the threshold values for Spo2, and by adjusting the correction parameter, CP, in accordance with the measured pH levels in the patient's blood as described above.
[0052] After the determination of the required Fκ)2, the procedure of adjusting the PEEP value is started at F in step 282. In this step, the ratio of PEEP/F102 is calculated. Then in 284, the control parameter AP, which was defined in step 208, is examined. If it is less than 1, it means that PEEP is not adjusted automatically and it is instead adjusted manually by the operator. In this case, the controller merely watches the PEEP/F102 ratio and generates warning signals, if the ratio is either too low or too high. In step 286, the ratio is compared to a minimum allowed value (e.g., 0.12). If it is less than the minimum value, an alarm is generated in 288 and control passes to I (which will be described later). However, if the PEEP/Frc^ ratio is found to be equal to or greater than the minimum value in step 286, then the next step in 290 is performed where the ratio is compared to a maximum allowed value (e.g., 0.22). If the ratio is less than or equal to the maximum value, control passes to I. Otherwise, an alarm is generated in step 292 and then control is transferred to I.
[0053] Back to step 284, if AP is not less than 1, it means that PEEP should be calculated and automatically adjusted. Therefore, the automatic PEEP adjustment control loop is started next at G at step 294. In the step 296 that follows, the PEEP/F- !02 ratio is compared to a minimum allowed value (e.g., 0.12). If it is less than the minimum, the procedure at H is started and it is examined how long ago the last adjustment in PEEP was made. In step 300 that follows, the time parameter, TP, is compared to a defined fixed interval, Tl, for example 240 seconds. If TP is less than 240 seconds, it means that the last PEEP adjustment was made less than 4 minutes ago. Then the procedure at J is started. Control passes to step 302 in which no change is made in PEEP and the time parameter, TP, is increased by a fixed amount (e.g., 0.75 seconds):
Figure imgf000021_0001
[0054] Thereafter, control passes to I. However, if in step 300, it is found that TP is equal to or greater than 240 seconds, it means that the last adjustment in PEEP was made at least 4 minutes ago or longer. Therefore, control passes to step 304. In this step, TP is set back to zero. Then in 306 that follows, PEEP is increased by a fixed amount (e.g., 2 cm H2O): PEEP(new) = PEEP(oid) + 2 cm H2O hereafter, control passes to I.
[0055] Back to step 296, if the PEEP/FI02 ratio is not found to be less than the minimum allowed value, control transfers to step 308. In this step the PEEP/F102 ratio is compared to a maximum allowed value (e.g., 0.22). If the ratio is not less than the maximum value, step 310 is next performed. At this point, the PEEP/F^ ratio is compared to a slightly higher value than the maximum, RG, (e.g., 0.24). If it is not greater than this value, control passes to J. Otherwise; step 312 is performed in which the time parameter, TP, is compared to the fixed interval of 240 seconds. If TP is less than 240 seconds, control passes to J. Otherwise; TP is set back to zero in step 314, and PEEP is reduced by a fixed amount (e.g., 2 cm H2O) in step 316: PEEP(new) = PEEP(old) - 2 cm H2O
[0056] Thereafter, control passes to I. In step 318 at I, the routine is held for a fixed interval (e.g., 0.75 seconds) and then control returns to the beginning of the main loop at A'.
[0057] Back to step 308, if the PEEP/TI02 ratio is found to be less than the maximum allowed limit (e.g., 0.22), the step 320 is next followed. In this step Spo2 is compared to a predefined minimum allowed value (e.g., 92%). If it is higher than or at least equal to the predefined minimum value, the PEEP level is not changed and control passes to J. However, if in 320, Spo2 is found to be less than the predefined minimum value, then control passes to H, where it is determined whether at least 4 minutes have passed since the last PEEP adjustment, and if so, PEEP is increased by a fixed amount (e. g., 2 cm H2O) as was shown earlier. [0058] In performing the automatic PEEP adjustments, the PEEP/F102 is kept within a clinically acceptable range. As shown above, if the PEEP/F102 is too low, PEEP is increased by a fixed increment (e.g., 2 cm H2O). Also, if the PEEP/F102 ratio is within the acceptable range and Spo2 is low, then PEEP is increased by a fixed increment (e.g., 2 cm H2O) to improve patient's oxygenation. On the other hand, if the PEEP/Fτo2 ratio increases beyond a maximum defined value, the program reduces PEEP in fixed amounts (e.g., 2 cm H2O). In any case, the interval between two successive PEEP adjustments is at least equal to a fixed period (e.g., 240 seconds), to allow for the changes in PEEP to have an observable and measurable impact on the patient's oxygenation.
[0059] It should be noted that the above examples for the incremental step size for PEEP adjustment (e.g. 2 cm H2O) and the minimum and maximum values for the ratio of PEEP/F102, are indicated for patients receiving ventilatory treatment in a more acute clinical setting such as the intensive care or a constant care unit of a hospital. Smaller incremental adjustments (e.g.l cm H2O) and more conservative ranges for the ratio of PEEP (or CPAP)/Fκ)2 may be adopted if the invention is used to improve the breathing and oxygenation of more stable, spontaneously breathing patients.
[0060] Figures 4a-c illustrate in detail, a preferred circuit diagram of the Signal Generator Circuit, 46, and the alarm circuit 54. The preferred component types and values are shown in the chart below:
Figure imgf000024_0001
[0061] There has been described a method and apparatus for controlling a ventilator. The invention utilizes data indicative of measured oxygen levels of the patient to automatically control F102, and PEEP (or CPAP). In an alternative embodiment, the invention further uses the respiratory mechanics data (i.e. respiratory elastance and airway resistance) to automatically make the necessary adjustments in the I:E ratio of the patient on the ventilator. It further incorporates the features of US Patent No. 4,986,268 and uses data indicative of measured levels of oxygen and the respiratory mechanics data of the patient, along with data indicative of barometric pressure (as a reference calibrating pressure), and data indicative of measured carbon dioxide level of the patient to automatically control the breathing frequency and tidal volume of breaths of the patient on the ventilator. The invention also detects and corrects artifacts in the measured oxygen and carbon dioxide data and applies safety rules. In its different embodiments, the invention can improve total and/or assist ventilatory treatments provided to different patient groups.
[0062] The present invention may be embodied in other specific forms without departing from the scope and the essential attributes thereof. Therefore, reference should be made to the appended claims rather than to the foregoing specification, with regard to the scope of the invention.

Claims

Claims
What is claimed is: 1. An apparatus for automatically controlling a ventilator comprising: first means for processing data indicative of at least a measured oxygen level of a patient, and for providing output data indicative of: required concentration of oxygen in inspiratory gas of the patient (F102) and positive end-expiratory pressure (PEEP) for a next breath of the patient; wherein F102 is determined to reduce the difference between the measured oxygen level of the patient and a desired value; wherein PEEP is determined to keep a ratio of PEEP/F102 within a prescribed range and, while keeping the ratio within the prescribed range, to keep the measured oxygen level of the patient above a predefined value; and second means, operatively coupled to the first means, for providing control signals, based on the output data provided by the first means, to the ventilator; wherein the control signals provided to the ventilator automatically control PEEP, and F102, for a next breath of the patient.
2. The apparatus of claim 1 , wherein the first means comprises a programmable microcomputer.
3. The apparatus of claim 2, further comprising an alarm unit; wherein the first means further determines whether there has been an artifact in the measured oxygen levels and replaces and/or corrects the data determined to be based on the artifact; and wherein the second means further provides an alarm control signal to the alarm unit to warn of the artifact in the measured oxygen levels.
4. The apparatus of claim 2, further comprising an alarm unit; wherein the first means further determines whether the measured oxygen levels are outside a prescribed range; and wherein the second means further provides an alarm control signal to the alarm unit to warn of the measured oxygen level of the patient being outside a prescribed range.
5. The apparatus of claim 2, further comprising an analog to digital (A/D) converter connected to an input of the first means for converting analog signals from an oxygen sensor, indicative of the oxygen level of the patient, to digital data.
6. The apparatus of claim 5, wherein the oxygen sensor is a pulse oximeter measuring arterial hemoglobin oxygen saturation in the patient's blood.
7. The apparatus of claim 2, wherein data indicative of the lower inflection pressure point on an inspiratory or expiratory pressure volume curve of the patient (LIP) is provided to the first means.
8. The apparatus of claim 7, wherein the data indicative of LIP is supplied by a monitor operatively coupled to the first means.
9. The apparatus of claim 2, wherein data indicative of the patient's measured intrinsic positive end-expiratory pressure (PEEPi) is provided to the first means.
10. The apparatus of claim 9, wherein the data indicative of PEEPi is supplied by a monitor operatively coupled to the first means.
11. The apparatus of claim 2, wherein the programmable microcomputer further comprises a program means for determining from the input data: the patient's arterial partial pressure of oxygen; the required F102; the required PEEP; for a next breath of the patient.
12. The apparatus of claim 11, wherein the program means further determines from the input data: whether there has been an artifact in the data indicative of the measured oxygen level of the patient, and wherein the program means further replaces and/or corrects the data based on the artifact and generates a warning signal in the event the artifact is determined.
13. The apparatus of claim 2, wherein data corresponding to a set point for arterial partial pressure of oxygen, threshold values for the oxygen level of the patient, and a correction factor for oxygen based on measured blood pH levels of the patient are entered manually and stored in a software program.
14. The apparatus of claim 2, wherein the first means further processes input data indicative of respiratory elastance, respiratory airway resistance, barometric pressure, and measured carbon dioxide levels of the patient, and based upon the input data, provides digital output data indicative of required ventilation, optimum breathing frequency, and required adjustment in the ratio of inspiration time to expiration time (I:E) for a next breath of the patient, and; wherein the second means further generates additional control signals to the ventilator based on the output data of the first means; wherein the additional control signals to the ventilator control tidal volume and frequency of inhaled gas provided to the patient by the ventilator and effect necessary adjustments in the ratio of I:E for a next breath of the patient.
15. The apparatus of claim 14, wherein the input data indicative of respiratory elastance and airway resistance of the patient are supplied to the first means by one or more monitors coupled to the first means.
16. The apparatus of claim 14, wherein the input data indicative of respiratory elastance and airway resistance of the patient are entered manually and stored in a software program.
17. The apparatus of claim 14, wherein the input data indicative of the measured oxygen level of the patient and the measured carbon dioxide level of the patient are provided to the first means by one or more monitors coupled to the first means.
18. The apparatus of claim 17, wherein the input data indicative of the measured oxygen level of the patient is provided by a pulse oximeter measuring arterial hemoglobin oxygen saturation of the patient, and the input data indicative of the measured carbon dioxide level of the patient is provided by an exhaled gas analyzer detecting end-tidal partial pressure of carbon dioxide or end-tidal concentration of carbon dioxide in exhaled gas of the patient.
19. The apparatus of claim 14, wherein the input data indicative of barometric pressure is supplied to the first means by one or more monitors coupled to the first means.
20. The apparatus of claim 14, wherein the input data indicative of barometric pressure is entered manually and stored in hardware.
21. The apparatus of claim 14, wherein the input data indicative of barometric pressure is entered manually and stored in a software program.
22. The apparatus of claim 17, wherein, based on data indicative of measured oxygen and carbon dioxide levels of the patient, the first means detects an artifact in the data, discards the data having the artifact, resumes a previous value of the data in a memory, and provides a warning instruction signal; and wherein the second means generates a warning control signal that is supplied to an alarm unit that generates an alarm signal.
23. The apparatus of claim 17, wherein, based on data indicative of measured carbon dioxide and oxygen levels of the patient, the first means detects a potential pulmonary embolism and produces digital output data indicative of predefined levels of ventilation and breathing frequency and a required adjustment in the I:E ratio, and provides a warning instruction signal; and wherein the second means generates a warning control signal.
24. The apparatus of claim 17, further comprising program means for determining from the input data: (i) partial pressures of oxygen and carbon dioxide in arterial blood of the patient; (ii) presence of artifact(s) in the data indicative of the measured oxygen and carbon dioxide levels of the patient, and in case of artifact detection, replacing and/or correcting the data and corresponding partial pressure value(s); (iii) net effects of oxygen and carbon dioxide on alveolar ventilation; (iv) total required alveolar ventilation; (v) optimal frequency of breathing; (vi) required ventilation; (vii) required adjustment in the I:E ratio; (viii) required F102; and (ix) required PEEP; for a next breath of the patient.
25. The apparatus of claim 24, wherein data corresponding to a set point for arterial partial pressure of oxygen, an adjustment factor for carbon dioxide level of the patient, threshold levels for oxygen level of the patient, and a correction factor for oxygen based on measured blood pH levels of the patient, are entered manually and stored in a software program.
26. The apparatus of claim 14, wherein the first means also receives and processes data indicative of the patient's metabolic rate ratio.
27. The apparatus of claim 26, wherein the data indicative of the patient's metabolic rate ratio is supplied to the first means by a monitor coupled to the first means.
28. The apparatus of claim 26, wherein the data indicative of the patient's metabolic rate ratio is entered manually and stored in a software program.
29. A method for automatically controlling a ventilator comprising the steps of: (a) measuring an oxygen level of a patient and providing a data signal indicative of the measured oxygen level; (b) determining: (i) required concentration of oxygen in an inspiratory gas of the patient, F102, based on the data signal indicative of the measured oxygen level of the patient and to reduce the difference between the measured oxygen level of the patient and a desired value; (ii) required positive end-expiratory pressure, PEEP, wherein a ratio of PEEP/F102 is maintained within a prescribed range, and to keep the measured oxygen level of the patient above a predefined value; and (c) providing data signals indicative of the required Fκ)2 and the required PEEP based upon the determining of step (b), for automatically controlling Fτo2 and PEEP for a next breath of the patient.
30. The method of claim 29, wherein step (b) further comprises determining, from the data indicative of the measured oxygen level in (a), whether there has been an artifact in the measured oxygen level, and replacing and/or correcting the data signal in (a) in the event the artifact is determined.
31. The method of claim 29, wherein the data signal indicative of measured oxygen level of the patient is in analog form and is converted to digital form before the determining of step (b), and wherein the providing of step (c) further comprises converting the data signals from digital to analog form.
32. The method of claim 29, wherein data corresponding to the lower inflection pressure point on an inspiratory or expiratory pressure volume curve of the patient (LIP) is also provided in step (a), and an initial value for PEEP is set equal to LIP plus 0 to 8 cm H2O and the initial value for PEEP is provided in step (b).
33. The method of claim 32, wherein the data corresponding to LIP is supplied by a monitor.
34. The method of claim 29, wherein data corresponding to the measured intrinsic PEEP of the patient (PEEPi) is also provided in step (a), and an initial value for PEEP is set between 80% and 100% of PEEPi and the initial value for PEEP is provided in step (b).
35. The method of claim 34, wherein the data corresponding to PEEPi is supplied by a monitor.
36. The method of claim 29, wherein an initial value for PEEP is determined by the operator and is manually provided.
37. The method of claim 31, wherein the measuring of the oxygen level of the patient comprises measuring an arterial hemoglobin oxygen saturation of the patient via pulse oximetry.
38. The method of claim 37, wherein an arterial partial pressure of oxygen of the patient is derived from the arterial hemoglobin oxygen saturation of the patient measured by the pulse oximeter.
39. The method of claim 38, wherein the following equation is used to calculate the arterial partial pressure of oxygen (Pao2) of the patient from the arterial hemoglobin oxygen saturation data (Spo2) measured by pulse oximetry:
- ln [l -(Sp0 H PaQ = + CP 2 0.046 where Pao2 is in mm Hg and CP is a correction parameter which is used to shift Pao2 and CP is based on the patient's measured blood pH level.
40. The method of claim 39, further comprising: comparing Pao2 to a minimum acceptable value, and, if Paθ2 is found to be less than the minimum acceptable value: discarding Pao2 and a latest measured Spo2 data; resuming previous values of Pao2 and Spo2 ; and generating a warning signal.
41. The method of claim 29, wherein the required concentration of oxygen in the inspiratory gas of the patient (Fιo2) is calculated by using a stepwise control scheme and/or by using a proportional-integral-derivative (PID) technique.
42. The method of claim 41, wherein using a PID technique comprises comparing Spo2 obtained by pulse oximetry to a defined minimum safe value, and wherein using the PID technique continues while Spo2 is greater than the defined minimum safe value.
43. The method of claim 41 , wherein using a PID technique comprises comparing Spo2 obtained by pulse oximetry to a defined minimum safe value, and wherein, if Spo2 is found to be less than or equal to the defined minimum safe value, a stepwise control scheme is followed that comprises the steps of: raising F102 stepwise to avoid hypoxemia, allowing Fκ)2 to remain high until Spo2 rises to a second threshold value, lowering F102 stepwise, comparing Spo2 to a third threshold value, lowering F102 stepwise upon Spo2 rising to the third threshold value, comparing Spo2 to a fourth threshold value, returning control to the PID technique upon Spo2 rising to the fourth threshold value.
44. The method of claim 41, wherein the difference between a Pao2 set point and the Pao2 of the patient is reduced by using a PUD control procedure according to the following equations: Yι(k) = Pa02(set-point) - Pa02 Y2(k) = [Y1(k) - Y1(k-l)]/T Y3(k) = Y3(k-l) +TYi(k) E(k) = αYi (k) +β Y3(k) +γY2(k)
G(k) = E(k) +0.21 where Y^k), Y2( ), and Y3(k) are the proportional, derivative, and integral components of error, respectively, E(k) is an error function, T is a sampling interval, G(k) is the required F102, and parameters α, β, and γ are PID coefficients.
45. The method of claim 41 , wherein the determining of required PEEP of the patient comprises the following procedure: comparing the PEEP/F102 ratio to a defined minimum allowed value, increasing PEEP by a fixed incremental value if the PEEP/Fιo2 ratio is lower than the defined minimum allowed value and the time elapsed since the last adjustment in PEEP is longer than or equal to a fixed defined interval Tl, comparing the PEEP/Fτo2 ratio with a defined maximum allowed value if the PEEP/Fκ)2 ratio is not less than the defined minimum allowed value, comparing Spo2 with a defined value if the PEEP/Fjo2 ratio is less than the defined maximum allowed value, increasing PEEP by a fixed incremental value if Spo2 is less than the defined value and the time elapsed since the last adjustment in PEEP is longer than or equal to Tl, if the PEEP/F102 ratio is not less than the defined maximum allowed value, comparing the PEEP/F^ ratio to a value higher than the defined maximum allowed value, RG, whereby if the PEEP/F102 ratio is higher than RG, and the time elapsed since the last adjustment in PEEP is greater than or equal to Tl, decreasing PEEP by a fixed incremental amount.
46. A method for automatically controlling a ventilator comprising the steps of: (a) measuring an oxygen level of a patient, and providing data indicative of the measured oxygen level of the patient; (b) measuring a carbon dioxide level of the patient and providing data indicative of the measured carbon dioxide level of the patient; (c) providing data indicative of respiratory elastance, respiratory airway resistance of the patient, and barometric pressure; (d) determining, from the data indicative of the measured oxygen level of the patient provided in (a), a required concentration of oxygen in an inspiratory gas of the patient, Fτo2, to reduce a difference between the measured oxygen level of the patient and a desired value, and providing a data signal indicative of the required Frø2; (e) determining a required positive end-expiratory pressure, PEEP, and providing a data signal indicative of the required PEEP, wherein the required PEEP maintains a ratio of PEEP/F102 within a prescribed range, and while the ratio is maintained within the prescribed range, to keep the measured oxygen level of the patient above a predefined value; (f) determining, based upon the data provided in (a), (b), and (c), an optimal breathing frequency, a required ventilation, and a required adjustment in inspiration to expiration time ratio, I:E, for a next breath of the patient, and providing data signals indicative of the same; and, (g) providing to the ventilator, based upon the data signals provided in (d), (e) and (f), final data signals for automatically controlling: (i) the required Fιo2,(ii) the required PEEP, (iii) the optimal breathing frequency, (iv) the required ventilation, (v) the required adjustment in I:E ratio, for a next breath of the patient.
47. The method of claim 46, wherein step (a) further comprises detecting an artifact in the data indicative of the measured oxygen level of the patient and correcting and/or replacing the data if an artifact is present.
48. The method of claim 46, wherein the determining of step (f) of the optimal breathing frequency, the required ventilation, and the required adjustment in I:E ratio is based upon minimization of a work rate of breathing for a next breath of the patient.
49. The method of claim 46, wherein the measuring of step (a) comprises measuring an arterial hemoglobin oxygen saturation in the patient's blood by a pulse oximeter.
50. The method of claim 46, wherein the measuring of step (b) comprises obtaining data from an exhaled gas analyzer.
51. The method of claim 46, further comprising derivation of arterial partial pressures of carbon dioxide and oxygen of the patient by using the following equations: PaC02 = PetCθ2 + Kj
Figure imgf000037_0001
where Paco2 and Pao2 are arterial partial pressures of carbon dioxide and oxygen of the patient, respectively; Petco2 is end-tidal carbon dioxide partial pressure of the patient supplied by an exhaled gas analyzer; Spo2 is an arterial hemoglobin oxygen saturation of the patient measured by a pulse oximeter; Ki is a difference between the arterial and end-tidal partial pressures of carbon dioxide and K\ can be adjusted to set a desired Paco2 level of the patient; CP is a correction parameter to shift and correct Pao2 in relation to Spo2 and is adjusted based on measured pH level in the patient's blood.
52. The method of claim 51 , wherein Pao2 is compared to a defined minimum acceptable value for oxygen; and wherein if Pao2 is below the defined minimum acceptable value, Pao2 and Spo2 are discarded and replaced by corresponding previous data values in memory, and a warning signal indicative of detection of an artifact is provided.
53. The method of claim 52, wherein Paco2 is compared to a defined minimum acceptable value for carbon dioxide; and wherein if Paco2 is below the defined minimum acceptable value, Paco2 is discarded and replaced by a corresponding previous data value in memory, and a warning signal indicative of detection of an artifact is provided.
54. The method of claim 53, wherein Paco2 and Pao2 are further compared to respective predefined minimum threshold values; if both Paco2 and Pao2 are found to be less than the predefined minimum threshold values, the method further comprises providing to the ventilator a predefined ventilation and breathing frequency, a required adjustment in I:E ratio, and a warning signal indicative of possibility of pulmonary embolism.
55. The method of claim 53, wherein Paco2 and Pao2 are compared to respective predefined ranges, and if either Paco2 or Pao2 is outside the corresponding predefined range, a warning signal is provided.
56. The method of claim 53, wherein a net effect of carbon dioxide on the required ventilation is calculated as: Vc = C,PaCo2 - C2 where Vc is a ratio of alveolar ventilation as a net effect of carbon dioxide to a resting value of ventilation, and Ci and C2 are constant parameters.
57. The method of claim 56, wherein Pao2 is compared to a high threshold value, whereby if Pao2 is higher than or equal to the high threshold value, a net effect of oxygen on the required ventilation is set to zero, and if Pao2 is less than the high threshold value, the net effect of oxygen on the required ventilation is calculated by using the following equation: V0 = (4.72x10"9)(104 - Pa02)49 where Vo is a ratio of alveolar ventilation as a net effect of oxygen to the resting value of ventilation.
58. The method of claim 57, wherein data indicative of a metabolic rate ratio, MRR, of the patient is also provided, and a required alveolar ventilation of the patient is calculated as: VM = 0.988 (MRR-1)
VA = (VA at rest)(Vc +V0 +VM) where VM is a ratio of alveolar ventilation as a net effect of increase in MRR to a resting value of ventilation, VA at rest is the patient's resting value of alveolar ventilation, and VA is the required alveolar ventilation of the patient.
59. The method of claim 58, wherein the data indicative of MRR of the patient is provided by a monitor.
60. The method of claim 58, wherein the data indicative of MRR of the patient is entered manually and stored in a software program.
61. The method of claim 58, wherein a physiological dead space of the patient is calculated, and a total dead space is found by using the following equations: VD =( .1698VA/60) + 0.1587 VDt = VD + VED where VD is the physiological dead space of the patient, VED is a dead space due to tubes and connections, and Vot is the total dead space.
62. The method of claim 61, wherein the optimal breathing frequency is calculated by using the following equation: -K'VD +. (K'VD)2 + 4K*K'1H2VARVD
2κ"π2v D where: f is the optimal breathing frequency, K is the respiratory elastance, which is the reciprocal of respiratory compliance, K is the respiratory airway resistance, VD is the physiological dead space of the patient, and VAR is the alveolar ventilation per second.
63. The method of claim 62, wherein minute ventilation and tidal volume for a next breath of the patient are calculated as: VE = VA +60fVDt Vτ = VA/60f + VDt where VE is minute ventilation and Vj is tidal volume.
64. The method of claim 46, wherein an input data corresponding to a lower inflection pressure point on an inspiratory or expiratory pressure volume curve of the patient (LIP) is also provided in step (c), and an initial value for PEEP is set equal to LIP plus 0 to 8 cm H2O.
65. The method of claim 64, wherein the input data coπesponding to LIP is supplied by a monitor.
66. The method of claim 46, wherein data corresponding to an intrinsic PEEP (PEEPi) of the patient is also provided in step (c), and an initial value for PEEP is set equal to between 80% to 100% of PEEPi.
67. The method of claim 66, wherein the data corresponding to the PEEPi is supplied by a monitor.
68. The method of claim 46, wherein an initial value for PEEP is determined by an operator and is manually supplied.
69. The method of claim 46, wherein the required Frø2 is calculated by using a stepwise control scheme and/or by using a proportional-integral-derivative (PID) control technique.
70. The method of claim 69, wherein, while using the PID technique, Spo2 obtained by pulse oximetry is compared to a defined minimum safe value, and if Spo2 is greater than the defined minimum safe value, control remains in the PID technique.
71. The method of claim 70, wherein, while using the PID technique, if Spo2 is found to be less than or equal to the defined minimum safe value, a stepwise control scheme is followed that comprises the following steps: (i) Fκ)2 is raised stepwise to avoid hypoxemia, (ii) F102 remains raised until Spo2 rises to a second threshold value, (iii) Fio2 is lowered stepwise, (iv) Spo2 is compared to a third threshold value, (v) when Spo2 rises to the third threshold value, F^ is further lowered stepwise, (vi) Spo2 is compared to a fourth threshold value, (vii) when Spo2 rises to the fourth threshold value, control switches to the PID technique.
72. The method of claim 69, wherein a difference between a Pao2 set point and the Paθ2 of the patient is reduced by using the PID technique according to the following equations: Yι(k) = Pa02(set-point) - Pa02 Y2(k) = [Y1(k) - Y1(k-l)]/T
Y3(k) = Y3(k-l) +TYι( ) E(k) = αY,(k) +βY3(k) +γY2(k)
G(k) = E(k) +0.21 where Yι(k), Y2(k), and Y3(k) are proportional, derivative, and integral components of error, respectively, E(k) is an error function, T is a sampling interval, G(k) is the required Fτo2, and parameters α, β, and γ are PID coefficients.
73. The method of claim 69, wherein the required PEEP is determined by the following procedure: the PEEP/F102 ratio is compared to a defined minimum allowed value, PEEP is increased by a fixed incremental value if the PEEP/F102 ratio is lower than the defined minimum allowed value and a time elapsed since a last adjustment in PEEP is longer than or equal to a fixed defined interval Tl, if the PEEP/F102 ratio is not less than the defined minimum allowed value, then the PEEP/Fτo2 ratio is compared with a defined maximum allowed value, if the PEEP/F102 ratio is less than the defined maximum allowed value, Spo2 is compared with a defined value; whereby if Spo2 is also less than the defined value and a time elapsed since the last adjustment in PEEP is longer than or equal to Tl, PEEP is increased by a fixed incremental value, if the PEEP/FK32 ratio is not less than the defined maximum allowed value, the
PEEP/F102 ratio is compared to a value higher than the defined maximum limit, RG; if the PEEP/F102 ratio is higher than RG and a time elapsed since a last adjustment in PEEP is greater than or equal to Tl, PEEP is decreased by a fixed incremental amount.
74. The method of claim 62, wherein a ratio of K /K is compared to one fifth of a reciprocal of the optimal breathing frequency; whereby if K/K is greater than one fifth of the reciprocal of the optimal breathing frequency, the breathing frequency is decreased to less than or equal to the reciprocal of five times K"/K'.
75. The method of claim 74, wherein an expiratory time, TE, is compared to 2.5 times K /K ; and wherein the I:E ratio is adjusted so that TE is greater than or equal to 2.5 times K7κ'.
76. The method of claim 46, wherein the data indicative of respiratory elastance and airway resistance of the patient are provided by one or more monitors.
77. The method of claim 46, wherein the data indicative of respiratory elastance and airway resistance of the patient are entered manually and stored in a software program.
78. The method of claim 46, wherein the data indicative of barometric pressure are provided by a monitor.
79. The method of claim 46, wherein the data indicative of barometric pressure is provided manually.
PCT/US2004/035393 2003-11-21 2004-10-25 Method and apparatus for controlling a ventilator WO2005051280A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA2545570A CA2545570C (en) 2003-11-21 2004-10-25 Method and apparatus for controlling a ventilator
NZ546941A NZ546941A (en) 2003-11-21 2004-10-25 Method and apparatus for controlling a ventilator
AU2004292955A AU2004292955B2 (en) 2003-11-21 2004-10-25 Method and apparatus for controlling a ventilator
GB0611065A GB2423721B (en) 2003-11-21 2004-10-25 Method and apparatus for controlling a ventilator

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US48169303P 2003-11-21 2003-11-21
US60/481,693 2003-11-21
US10/935,446 US7802571B2 (en) 2003-11-21 2004-09-07 Method and apparatus for controlling a ventilator
US10/935,446 2004-09-07

Publications (2)

Publication Number Publication Date
WO2005051280A2 true WO2005051280A2 (en) 2005-06-09
WO2005051280A3 WO2005051280A3 (en) 2006-05-26

Family

ID=34594521

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/035393 WO2005051280A2 (en) 2003-11-21 2004-10-25 Method and apparatus for controlling a ventilator

Country Status (6)

Country Link
US (1) US7802571B2 (en)
AU (1) AU2004292955B2 (en)
CA (1) CA2545570C (en)
GB (1) GB2423721B (en)
NZ (1) NZ546941A (en)
WO (1) WO2005051280A2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1930043A2 (en) 2006-12-05 2008-06-11 Weinmann Geräte für Medizin GmbH & Co. KG Method and device for mixing oxygen into a breathing gas mixture
GB2472116A (en) * 2009-07-25 2011-01-26 Fleur T Tehrani A method and an apparatus for controlling a ventilator to automatically adjust ventilation assistance to an active or passive subject
WO2012080903A1 (en) 2010-12-17 2012-06-21 Koninklijke Philips Electronics N.V. System and method for customizable automated control of fraction of inspired oxygen and/or positive end expiratory pressure to maintain oxygenation
US8528552B2 (en) 2008-12-01 2013-09-10 Dräger Medical GmbH SPO2 control with adaptive linear compensation
US8640700B2 (en) 2008-03-27 2014-02-04 Covidien Lp Method for selecting target settings in a medical device
US10514662B1 (en) 2015-01-22 2019-12-24 Vapotherm, Inc. Oxygen mixing and delivery
US11324954B2 (en) 2019-06-28 2022-05-10 Covidien Lp Achieving smooth breathing by modified bilateral phrenic nerve pacing
US11612706B2 (en) 2019-11-25 2023-03-28 John C. Taube Methods, systems, and devices for controlling mechanical ventilation
US11779720B2 (en) 2019-11-04 2023-10-10 Vapotherm, Inc. Methods, devices, and systems for improved oxygenation patient monitoring, mixing, and delivery
US12053588B2 (en) 2014-12-31 2024-08-06 Vapotherm, Inc. Systems and methods for humidity control
US12064562B2 (en) 2020-03-12 2024-08-20 Vapotherm, Inc. Respiratory therapy unit with non-contact sensing and control

Families Citing this family (160)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6782888B1 (en) * 1999-04-07 2004-08-31 Event Medical Ltd. Breathing apparatus
US9053222B2 (en) 2002-05-17 2015-06-09 Lawrence A. Lynn Patient safety processor
WO2004075746A2 (en) 2003-02-27 2004-09-10 Cardiodigital Limited Method and system for analysing and processing ph0t0plethysmogram signals using wavelet transform
WO2005009291A2 (en) * 2003-07-23 2005-02-03 Synapse Biomedical, Inc. System and method for conditioning a diaphragm of a patient
US7415297B2 (en) * 2004-03-08 2008-08-19 Masimo Corporation Physiological parameter system
US20070044669A1 (en) * 2005-08-24 2007-03-01 Geise Gregory D Aluminum can compacting mechanism with improved actuation handle assembly
US9050005B2 (en) * 2005-08-25 2015-06-09 Synapse Biomedical, Inc. Method and apparatus for transgastric neurostimulation
US20070077200A1 (en) * 2005-09-30 2007-04-05 Baker Clark R Method and system for controlled maintenance of hypoxia for therapeutic or diagnostic purposes
JP2009519050A (en) * 2005-12-02 2009-05-14 シナプス・バイオメディカル・インコーポレイテッド Trans visceral nerve stimulation mapping apparatus and method
WO2007085110A1 (en) * 2006-01-30 2007-08-02 Hamilton Medical Ag O2-controller
US8676323B2 (en) * 2006-03-09 2014-03-18 Synapse Biomedical, Inc. Ventilatory assist system and methods to improve respiratory function
US7909033B2 (en) 2006-05-03 2011-03-22 Comedica Incorporated Breathing treatment apparatus
US8667963B2 (en) * 2006-05-16 2014-03-11 Impact Instrumentation, Inc. Ventilator circuit for oxygen generating system
US8051854B2 (en) * 2006-09-15 2011-11-08 Comedica Incorporated Continuous high-frequency oscillation breathing treatment apparatus
US20080066752A1 (en) * 2006-09-20 2008-03-20 Nellcor Puritan Bennett Inc. Method and system for circulatory delay compensation in closed-loop control of a medical device
US8728059B2 (en) * 2006-09-29 2014-05-20 Covidien Lp System and method for assuring validity of monitoring parameter in combination with a therapeutic device
EP2091429B1 (en) * 2006-11-16 2010-11-10 Hamilton Medical AG Method and device for determining the peep during the respiration of a patient
CA3000408C (en) 2007-01-29 2024-04-02 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus and methods
US9079016B2 (en) * 2007-02-05 2015-07-14 Synapse Biomedical, Inc. Removable intramuscular electrode
US20080202521A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20080202519A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20080202518A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20080202520A1 (en) 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20080202517A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting madatory mechanical ventilation parameters based on patient physiology
EP1961438A1 (en) * 2007-02-23 2008-08-27 The General Electric Company Inhalation anaesthesia delivery system and method
US20080230061A1 (en) * 2007-03-23 2008-09-25 General Electric Company Setting expiratory time in mandatory mechanical ventilation based on a deviation from a stable condition of end tidal gas concentrations
US20080230064A1 (en) * 2007-03-23 2008-09-25 General Electric Company Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when forced inhalation flow ceases
US20080230063A1 (en) * 2007-03-23 2008-09-25 General Electric Company Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as forced inhalation time
US20080230060A1 (en) * 2007-03-23 2008-09-25 General Electric Company Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when tidal volume is inspired
US8695593B2 (en) * 2007-03-31 2014-04-15 Fleur T. Tehrani Weaning and decision support system for mechanical ventilation
US8316849B2 (en) * 2007-04-26 2012-11-27 Buxco Electronics, Inc. Integrated ventilator with calibration
WO2008144578A1 (en) * 2007-05-17 2008-11-27 Synapse Biomedical, Inc. Devices and methods for assessing motor point electromyogram as a biomarker
US9050434B2 (en) * 2007-05-18 2015-06-09 Comedica Incorporated Lung therapy device
US8478412B2 (en) * 2007-10-30 2013-07-02 Synapse Biomedical, Inc. Method of improving sleep disordered breathing
US8428726B2 (en) 2007-10-30 2013-04-23 Synapse Biomedical, Inc. Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system
US9078984B2 (en) * 2008-01-31 2015-07-14 Massachusetts Institute Of Technology Mechanical ventilator
US8746248B2 (en) 2008-03-31 2014-06-10 Covidien Lp Determination of patient circuit disconnect in leak-compensated ventilatory support
US8272380B2 (en) 2008-03-31 2012-09-25 Nellcor Puritan Bennett, Llc Leak-compensated pressure triggering in medical ventilators
US8267085B2 (en) 2009-03-20 2012-09-18 Nellcor Puritan Bennett Llc Leak-compensated proportional assist ventilation
EP2313138B1 (en) 2008-03-31 2018-09-12 Covidien LP System and method for determining ventilator leakage during stable periods within a breath
US8425428B2 (en) 2008-03-31 2013-04-23 Covidien Lp Nitric oxide measurements in patients using flowfeedback
US8251876B2 (en) 2008-04-22 2012-08-28 Hill-Rom Services, Inc. Breathing exercise apparatus
WO2009137682A1 (en) 2008-05-07 2009-11-12 Lynn Lawrence A Medical failure pattern search engine
US8457706B2 (en) 2008-05-16 2013-06-04 Covidien Lp Estimation of a physiological parameter using a neural network
EP2320791B1 (en) 2008-06-06 2016-08-31 Covidien LP Systems for ventilation in proportion to patient effort
US8398555B2 (en) * 2008-09-10 2013-03-19 Covidien Lp System and method for detecting ventilatory instability
US8551006B2 (en) 2008-09-17 2013-10-08 Covidien Lp Method for determining hemodynamic effects
US8794234B2 (en) 2008-09-25 2014-08-05 Covidien Lp Inversion-based feed-forward compensation of inspiratory trigger dynamics in medical ventilators
US8652064B2 (en) * 2008-09-30 2014-02-18 Covidien Lp Sampling circuit for measuring analytes
US8302602B2 (en) 2008-09-30 2012-11-06 Nellcor Puritan Bennett Llc Breathing assistance system with multiple pressure sensors
US9155493B2 (en) 2008-10-03 2015-10-13 Nellcor Puritan Bennett Ireland Methods and apparatus for calibrating respiratory effort from photoplethysmograph signals
US9011347B2 (en) 2008-10-03 2015-04-21 Nellcor Puritan Bennett Ireland Methods and apparatus for determining breathing effort characteristics measures
US8428672B2 (en) * 2009-01-29 2013-04-23 Impact Instrumentation, Inc. Medical ventilator with autonomous control of oxygenation
US8424521B2 (en) 2009-02-27 2013-04-23 Covidien Lp Leak-compensated respiratory mechanics estimation in medical ventilators
US20100224191A1 (en) * 2009-03-06 2010-09-09 Cardinal Health 207, Inc. Automated Oxygen Delivery System
US10426906B2 (en) 2009-03-18 2019-10-01 Mayo Foundation For Medical Education And Research Ventilator monitoring and control
US8418691B2 (en) 2009-03-20 2013-04-16 Covidien Lp Leak-compensated pressure regulated volume control ventilation
US8408203B2 (en) * 2009-04-30 2013-04-02 General Electric Company System and methods for ventilating a patient
US8550077B2 (en) * 2009-05-19 2013-10-08 The Cleveland Clinic Foundation Ventilator control system utilizing a mid-frequency ventilation pattern
US8444570B2 (en) * 2009-06-09 2013-05-21 Nellcor Puritan Bennett Ireland Signal processing techniques for aiding the interpretation of respiration signals
US20100331716A1 (en) * 2009-06-26 2010-12-30 Nellcor Puritan Bennett Ireland Methods and apparatus for measuring respiratory function using an effort signal
US20100331715A1 (en) * 2009-06-30 2010-12-30 Nellcor Puritan Bennett Ireland Systems and methods for detecting effort events
US8755854B2 (en) 2009-07-31 2014-06-17 Nellcor Puritan Bennett Ireland Methods and apparatus for producing and using lightly filtered photoplethysmograph signals
US8789529B2 (en) 2009-08-20 2014-07-29 Covidien Lp Method for ventilation
US8596270B2 (en) * 2009-08-20 2013-12-03 Covidien Lp Systems and methods for controlling a ventilator
US20110100360A1 (en) * 2009-11-02 2011-05-05 Joseph Dee Faram Composite lung therapy device and method
US9151425B2 (en) * 2009-11-02 2015-10-06 Comedica Incorporated Multiple conduit connector apparatus and method
US8638200B2 (en) 2010-05-07 2014-01-28 Covidien Lp Ventilator-initiated prompt regarding Auto-PEEP detection during volume ventilation of non-triggering patient
JP2013533760A (en) * 2010-06-10 2013-08-29 オリディオン メディカル 1987 リミテッド Weaning from artificial respiration using capnography
US8607790B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during pressure ventilation of patient exhibiting obstructive component
US8607788B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during volume ventilation of triggering patient exhibiting obstructive component
US8607791B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during pressure ventilation
US8607789B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during volume ventilation of non-triggering patient exhibiting obstructive component
US8676285B2 (en) 2010-07-28 2014-03-18 Covidien Lp Methods for validating patient identity
US8834378B2 (en) 2010-07-30 2014-09-16 Nellcor Puritan Bennett Ireland Systems and methods for determining respiratory effort
US8554298B2 (en) 2010-09-21 2013-10-08 Cividien LP Medical ventilator with integrated oximeter data
JP6320755B2 (en) * 2010-11-23 2018-05-09 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Obesity hypoventilation syndrome treatment system and method
US8595639B2 (en) 2010-11-29 2013-11-26 Covidien Lp Ventilator-initiated prompt regarding detection of fluctuations in resistance
US8757153B2 (en) 2010-11-29 2014-06-24 Covidien Lp Ventilator-initiated prompt regarding detection of double triggering during ventilation
US8757152B2 (en) 2010-11-29 2014-06-24 Covidien Lp Ventilator-initiated prompt regarding detection of double triggering during a volume-control breath type
US9038633B2 (en) 2011-03-02 2015-05-26 Covidien Lp Ventilator-initiated prompt regarding high delivered tidal volume
US8714154B2 (en) 2011-03-30 2014-05-06 Covidien Lp Systems and methods for automatic adjustment of ventilator settings
US8776792B2 (en) 2011-04-29 2014-07-15 Covidien Lp Methods and systems for volume-targeted minimum pressure-control ventilation
US8801619B2 (en) 2011-06-30 2014-08-12 Covidien Lp Photoplethysmography for determining ventilation weaning readiness
US9089657B2 (en) 2011-10-31 2015-07-28 Covidien Lp Methods and systems for gating user initiated increases in oxygen concentration during ventilation
US9364624B2 (en) 2011-12-07 2016-06-14 Covidien Lp Methods and systems for adaptive base flow
US9498589B2 (en) 2011-12-31 2016-11-22 Covidien Lp Methods and systems for adaptive base flow and leak compensation
US9022031B2 (en) 2012-01-31 2015-05-05 Covidien Lp Using estimated carinal pressure for feedback control of carinal pressure during ventilation
CN107126622A (en) 2012-03-05 2017-09-05 西蒙·弗雷瑟大学 neural stimulation system
US9180271B2 (en) 2012-03-05 2015-11-10 Hill-Rom Services Pte. Ltd. Respiratory therapy device having standard and oscillatory PEP with nebulizer
US9024756B2 (en) * 2012-03-28 2015-05-05 J And N Enterprises Inc. Immediate detection system and method thereof
US8844526B2 (en) 2012-03-30 2014-09-30 Covidien Lp Methods and systems for triggering with unknown base flow
EP2830498A1 (en) * 2012-03-30 2015-02-04 Koninklijke Philips N.V. System and method for power of breathing real-time assessment and closed-loop controller
US9131881B2 (en) * 2012-04-17 2015-09-15 Masimo Corporation Hypersaturation index
US9993604B2 (en) 2012-04-27 2018-06-12 Covidien Lp Methods and systems for an optimized proportional assist ventilation
JP6359528B2 (en) 2012-06-21 2018-07-18 ラングペーサー メディカル インコーポレイテッドLungpacer Medical Inc. Transvascular diaphragm pacing system and method of use
US10362967B2 (en) 2012-07-09 2019-07-30 Covidien Lp Systems and methods for missed breath detection and indication
US9027552B2 (en) 2012-07-31 2015-05-12 Covidien Lp Ventilator-initiated prompt or setting regarding detection of asynchrony during ventilation
EP2895223B1 (en) 2012-09-12 2019-05-22 Maquet Critical Care AB An anesthesia system, a method and a computer-readable medium for actively controlling oxygen delivered to a patient
US9375542B2 (en) 2012-11-08 2016-06-28 Covidien Lp Systems and methods for monitoring, managing, and/or preventing fatigue during ventilation
US10354429B2 (en) 2012-11-14 2019-07-16 Lawrence A. Lynn Patient storm tracker and visualization processor
US9953453B2 (en) 2012-11-14 2018-04-24 Lawrence A. Lynn System for converting biologic particle density data into dynamic images
US12080401B2 (en) 2012-12-03 2024-09-03 Metrohealth Ventures Llc Combination respiratory therapy device, system and method
US9795752B2 (en) 2012-12-03 2017-10-24 Mhs Care-Innovation, Llc Combination respiratory therapy device, system, and method
US9492629B2 (en) 2013-02-14 2016-11-15 Covidien Lp Methods and systems for ventilation with unknown exhalation flow and exhalation pressure
WO2014134512A1 (en) 2013-02-28 2014-09-04 Lynn Lawrence A System and method for biologic particle density path projection
US9358355B2 (en) 2013-03-11 2016-06-07 Covidien Lp Methods and systems for managing a patient move
US9981096B2 (en) 2013-03-13 2018-05-29 Covidien Lp Methods and systems for triggering with unknown inspiratory flow
US10449311B2 (en) 2013-06-05 2019-10-22 Thornhill Scientific Inc. Controlling arterial blood gas concentration
WO2014194401A1 (en) * 2013-06-05 2014-12-11 Michael Klein Controlling arterial blood gas concentration
US9675771B2 (en) 2013-10-18 2017-06-13 Covidien Lp Methods and systems for leak estimation
US10022068B2 (en) 2013-10-28 2018-07-17 Covidien Lp Systems and methods for detecting held breath events
WO2015075548A1 (en) 2013-11-22 2015-05-28 Simon Fraser University Apparatus and methods for assisted breathing by transvascular nerve stimulation
CA2935454A1 (en) 2014-01-21 2015-07-30 Simon Fraser University Systems and related methods for optimization of multi-electrode nerve pacing
WO2015136405A1 (en) * 2014-03-11 2015-09-17 Koninklijke Philips N.V. Reducing hypercapnic respiratory failure during mechanical ventilation
US9839760B2 (en) * 2014-04-11 2017-12-12 Vyaire Medical Capital Llc Methods for controlling mechanical lung ventilation
US10183139B2 (en) 2014-04-11 2019-01-22 Vyaire Medical Capital Llc Methods for controlling mechanical lung ventilation
US9956365B2 (en) 2014-04-11 2018-05-01 Vyaire Medical Capital Llc Lung ventilation apparatus
US9808591B2 (en) 2014-08-15 2017-11-07 Covidien Lp Methods and systems for breath delivery synchronization
US20160058346A1 (en) * 2014-09-02 2016-03-03 General Electric Company Determination of arterial co2 partial pressure
US9950129B2 (en) 2014-10-27 2018-04-24 Covidien Lp Ventilation triggering using change-point detection
CN107427259B (en) * 2014-12-31 2021-03-16 皇家飞利浦有限公司 System for performing histogram analysis of time-based capnography signals and method of operation thereof
US9925346B2 (en) 2015-01-20 2018-03-27 Covidien Lp Systems and methods for ventilation with unknown exhalation flow
DE102015103894A1 (en) * 2015-03-17 2016-09-22 Fritz Stephan Gmbh Medizintechnik Respirators and control methods for ventilators
CN104834326B (en) * 2015-04-01 2017-12-19 深圳市科曼医疗设备有限公司 Lung ventilator oxygen concentration control method, device and system
WO2016159889A1 (en) 2015-04-02 2016-10-06 Hill-Rom Services Pte. Ltd. Manifold for respiratory device
WO2016210382A1 (en) * 2015-06-24 2016-12-29 Chris Salvino Oxygen biofeedback device and methods
WO2017079798A1 (en) * 2015-11-10 2017-05-18 University Of Tasmania Method, apparatus and system for automatically controlling inspired oxygen delivery
US11154215B2 (en) * 2016-12-05 2021-10-26 Medipines Corporation System and methods for respiratory measurements using breathing gas samples
US10357624B2 (en) * 2016-12-06 2019-07-23 Iasset Ag Ventilator apparatus and method for operating a ventilator in said ventilator apparatus
US11351320B2 (en) 2017-02-22 2022-06-07 Koninklijke Philips N.V. Automatic PEEP selection for mechanical ventilation
US10293164B2 (en) 2017-05-26 2019-05-21 Lungpacer Medical Inc. Apparatus and methods for assisted breathing by transvascular nerve stimulation
WO2019006239A1 (en) 2017-06-30 2019-01-03 Lungpacer Medical Inc. Devices for prevention, moderation, and/or treatment of cognitive injury
US10195429B1 (en) 2017-08-02 2019-02-05 Lungpacer Medical Inc. Systems and methods for intravascular catheter positioning and/or nerve stimulation
US10940308B2 (en) 2017-08-04 2021-03-09 Lungpacer Medical Inc. Systems and methods for trans-esophageal sympathetic ganglion recruitment
CN117563098A (en) 2017-10-06 2024-02-20 斐雪派克医疗保健有限公司 Breathing apparatus
AU2018353928B2 (en) 2017-11-14 2019-06-13 Covidien Lp Methods and systems for drive pressure spontaneous ventilation
US20190175908A1 (en) 2017-12-11 2019-06-13 Lungpacer Medical Inc. Systems and methods for strengthening a respiratory muscle
US11478594B2 (en) 2018-05-14 2022-10-25 Covidien Lp Systems and methods for respiratory effort detection utilizing signal distortion
CN108904938B (en) * 2018-07-20 2024-03-22 张锦洪 Simple respirator device with function of accurately measuring tidal volume
US11517691B2 (en) 2018-09-07 2022-12-06 Covidien Lp Methods and systems for high pressure controlled ventilation
US11933453B2 (en) * 2018-09-25 2024-03-19 3M Innovative Properties Company Dynamically determining safety equipment for dynamically changing environments
US11752287B2 (en) 2018-10-03 2023-09-12 Covidien Lp Systems and methods for automatic cycling or cycling detection
EP3877043A4 (en) 2018-11-08 2022-08-24 Lungpacer Medical Inc. Stimulation systems and related user interfaces
WO2020103163A1 (en) * 2018-11-23 2020-05-28 深圳迈瑞生物医疗电子股份有限公司 Positive end expiratory pressure determining method and apparatus, aeration device, and storage medium
CN111888599B (en) * 2018-12-10 2022-10-04 深圳市科曼医疗设备有限公司 Pressure maintaining device of breathing machine
US11471683B2 (en) 2019-01-29 2022-10-18 Synapse Biomedical, Inc. Systems and methods for treating sleep apnea using neuromodulation
US20220133223A1 (en) * 2019-02-15 2022-05-05 Children's Medical Center Corporation Summarial scores for an emr platform
CN111694382B (en) * 2019-03-15 2024-06-25 欧姆龙健康医疗(中国)有限公司 Gas supply concentration adjusting method, gas supply concentration adjusting system and oxygenerator
JP2022532375A (en) 2019-05-16 2022-07-14 ラングペーサー メディカル インコーポレイテッド Systems and methods for detection and stimulation
WO2020252037A1 (en) 2019-06-12 2020-12-17 Lungpacer Medical Inc. Circuitry for medical stimulation systems
WO2021026621A1 (en) * 2019-08-12 2021-02-18 Britto Azevedo Schneider Felipe Pressure and flow generator for mechanical veterinary pulmonary ventilation
US12070554B2 (en) 2019-11-11 2024-08-27 Hill-Rom Services Pte. Ltd. Pneumatic connector apparatus and method
US11813399B2 (en) 2019-11-28 2023-11-14 Liauna Kelly Continuous positive airway pressure (CPAP) apparatus and system
DE102021000313A1 (en) * 2020-02-06 2021-08-12 Löwenstein Medical Technology S.A. Method for operating a ventilator for artificial ventilation of a patient and such a ventilator
CN112316264B (en) * 2020-11-24 2024-09-17 方梁 Wall breathing oxygen automatic device for hospital
EP4313226A1 (en) * 2021-03-30 2024-02-07 Zoll Medical Corporation Closed loop control in mechanical ventilation
WO2023122903A1 (en) * 2021-12-27 2023-07-06 深圳迈瑞生物医疗电子股份有限公司 Ventilation control method and device
DE102022117141A1 (en) 2022-07-08 2024-01-11 Löwenstein Medical Technology Sa Ventilator and method for supplying breathing gas
CN115887841B (en) * 2022-08-19 2024-08-20 湖南万脉医疗科技有限公司 Breathing machine flow control method based on sleep state and sleep breathing machine

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4986268A (en) * 1988-04-06 1991-01-22 Tehrani Fleur T Method and apparatus for controlling an artificial respirator
US5558086A (en) * 1992-12-16 1996-09-24 Freedom Air Services Method and apparatus for the intermittent delivery of oxygen therapy to a person
US6116241A (en) * 1996-07-08 2000-09-12 Siemens-Elema Ab Method and apparatus for determining when a partially or completely collapsed lung has been opened
US6158432A (en) * 1995-12-08 2000-12-12 Cardiopulmonary Corporation Ventilator control system and method

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2414747A (en) 1942-07-02 1947-01-21 Harry M Kirschbaum Method and apparatus for controlling the oxygen content of the blood of living animals
GB835192A (en) 1958-08-06 1960-05-18 Philip Lockland Stanton Pressure breathing therapy apparatus
US3734091A (en) 1971-06-22 1973-05-22 Airco Inc Oxygen control system with blood oxygen saturation sensing means and method for closed system breathing
US4121578A (en) 1976-10-04 1978-10-24 The Bendix Corporation Physiological responsive control for an oxygen regulator
DE2926747C2 (en) 1979-07-03 1982-05-19 Drägerwerk AG, 2400 Lübeck Ventilation system with a ventilator controlled by patient values
US4448192A (en) 1982-03-05 1984-05-15 Hewlett Packard Company Medical ventilator device parametrically controlled for patient ventilation
FR2530148B1 (en) 1982-07-13 1985-11-29 France Prod Oxygenes Co DEVICE FOR THE TREATMENT OF PATIENT RESPIRATORY FAILURE
US4665911A (en) 1983-11-25 1987-05-19 Electro-Fluidics Intermittent supplemental oxygen apparatus and method
US4584996A (en) 1984-03-12 1986-04-29 Blum Alvin S Apparatus for conservative supplemental oxygen therapy
US4773411A (en) 1986-05-08 1988-09-27 Downs John B Method and apparatus for ventilatory therapy
GB8719333D0 (en) 1987-08-14 1987-09-23 Swansea University College Of Motion artefact rejection system
US4889116A (en) 1987-11-17 1989-12-26 Phospho Energetics, Inc. Adaptive control of neonatal fractional inspired oxygen
US5103814A (en) 1988-04-28 1992-04-14 Timothy Maher Self-compensating patient respirator
US5532958A (en) * 1990-06-25 1996-07-02 Dallas Semiconductor Corp. Dual storage cell memory
US5632269A (en) 1989-09-22 1997-05-27 Respironics Inc. Breathing gas delivery method and apparatus
DE69131836T2 (en) 1990-09-19 2000-07-27 The University Of Melbourne, Parkville CONTROL CIRCUIT FOR MONITORING THE ARTERIAL CO 2 CONTENT
US5365922A (en) * 1991-03-19 1994-11-22 Brigham And Women's Hospital, Inc. Closed-loop non-invasive oxygen saturation control system
US5315990A (en) 1991-12-30 1994-05-31 Mondry Adolph J Method for delivering incremental doses of oxygen for maximizing blood oxygen saturation levels
US5682877A (en) 1991-12-30 1997-11-04 Mondry; Adolph J. System and method for automatically maintaining a blood oxygen saturation level
US5388575A (en) * 1992-09-25 1995-02-14 Taube; John C. Adaptive controller for automatic ventilators
DE4309923C2 (en) 1993-03-26 1995-02-16 Boesch Wilhelm Device for supplying breathing gas to a patient
DE69305178T2 (en) 1993-12-11 1997-02-13 Hewlett Packard Gmbh Method for detecting an abnormal condition in a pulse powered oximeter system
SE9400487L (en) 1994-02-14 1995-03-13 Siemens Elema Ab A ventilator / respirator
US6105575A (en) 1994-06-03 2000-08-22 Respironics, Inc. Method and apparatus for providing positive airway pressure to a patient
FI954092A (en) 1994-09-08 1996-03-09 Weinmann G Geraete Med Method of controlling a respirator in the treatment of sleep apnea
SE9502032D0 (en) 1995-06-02 1995-06-02 Burkhard Lachmann Arrangement for determining an opening pressure
SE9502543D0 (en) 1995-07-10 1995-07-10 Lachmann Burkhardt Artificial ventilation system
US6463930B2 (en) 1995-12-08 2002-10-15 James W. Biondi System for automatically weaning a patient from a ventilator, and method thereof
US6148814A (en) 1996-02-08 2000-11-21 Ihc Health Services, Inc Method and system for patient monitoring and respiratory assistance control through mechanical ventilation by the use of deterministic protocols
US5692497A (en) 1996-05-16 1997-12-02 Children's Medical Center Corporation Microprocessor-controlled ventilator system and methods
US5705735A (en) * 1996-08-09 1998-01-06 Medical Graphics Corporation Breath by breath nutritional requirements analyzing system
US6355022B1 (en) * 1998-05-01 2002-03-12 The Procter & Gamble Company Absorbent interlabial device with substance thereon for maintaining the device in position
AU8592898A (en) 1997-07-25 1999-02-16 Minnesota Innovative Technologies & Instruments Corporation (Miti) Control device for supplying supplemental respiratory oxygen
US6532958B1 (en) 1997-07-25 2003-03-18 Minnesota Innovative Technologies & Instruments Corporation Automated control and conservation of supplemental respiratory oxygen
US6371114B1 (en) 1998-07-24 2002-04-16 Minnesota Innovative Technologies & Instruments Corporation Control device for supplying supplemental respiratory oxygen
US6655382B1 (en) 1997-09-18 2003-12-02 The United States Of America As Represented By The Secretary Of Health And Human Services Spontaneous breathing apparatus and method
US5937854A (en) 1998-01-06 1999-08-17 Sensormedics Corporation Ventilator pressure optimization method and apparatus
SE9801175D0 (en) 1998-04-03 1998-04-03 Innotek Ab Method and apparatus for optimizing mechanical ventilation based on simulation of the ventilation process after studying the physiology of the respiratory organs
AUPP366398A0 (en) 1998-05-22 1998-06-18 Resmed Limited Ventilatory assistance for treatment of cardiac failure and cheyne-stokes breathing
US6390940B1 (en) * 1998-12-01 2002-05-21 William Naulls Basketball game, apparatus and method of play
EP1148907B1 (en) 1999-01-29 2003-12-10 Siemens-Elema AB Non-invasive method for optimizing the respiration of atelectatic lungs
US6390091B1 (en) 1999-02-03 2002-05-21 University Of Florida Method and apparatus for controlling a medical ventilator
DE60020842T2 (en) * 1999-06-30 2006-05-18 University of Florida Research Foundation, Inc., Gainesville MONITORING SYSTEM FOR VENTILATOR
US20070000494A1 (en) 1999-06-30 2007-01-04 Banner Michael J Ventilator monitor system and method of using same
US6355002B1 (en) 2000-05-22 2002-03-12 Comedica Technologies Incorporated Lung inflection point monitor apparatus and method
US6752151B2 (en) 2000-09-25 2004-06-22 Respironics, Inc. Method and apparatus for providing variable positive airway pressure
US6512938B2 (en) 2000-12-12 2003-01-28 Nelson R. Claure System and method for closed loop controlled inspired oxygen concentration
US7246618B2 (en) 2001-06-21 2007-07-24 Nader Maher Habashi Ventilation method and control of a ventilator based on same
US6575918B2 (en) 2001-09-27 2003-06-10 Charlotte-Mecklenburg Hospital Non-invasive device and method for the diagnosis of pulmonary vascular occlusions
ES2592262T3 (en) * 2003-08-04 2016-11-29 Carefusion 203, Inc. Portable respirator system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4986268A (en) * 1988-04-06 1991-01-22 Tehrani Fleur T Method and apparatus for controlling an artificial respirator
US5558086A (en) * 1992-12-16 1996-09-24 Freedom Air Services Method and apparatus for the intermittent delivery of oxygen therapy to a person
US6158432A (en) * 1995-12-08 2000-12-12 Cardiopulmonary Corporation Ventilator control system and method
US6116241A (en) * 1996-07-08 2000-09-12 Siemens-Elema Ab Method and apparatus for determining when a partially or completely collapsed lung has been opened

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1930043A2 (en) 2006-12-05 2008-06-11 Weinmann Geräte für Medizin GmbH & Co. KG Method and device for mixing oxygen into a breathing gas mixture
US8640700B2 (en) 2008-03-27 2014-02-04 Covidien Lp Method for selecting target settings in a medical device
US8640699B2 (en) 2008-03-27 2014-02-04 Covidien Lp Breathing assistance systems with lung recruitment maneuvers
US8528552B2 (en) 2008-12-01 2013-09-10 Dräger Medical GmbH SPO2 control with adaptive linear compensation
GB2472116A (en) * 2009-07-25 2011-01-26 Fleur T Tehrani A method and an apparatus for controlling a ventilator to automatically adjust ventilation assistance to an active or passive subject
GB2472116B (en) * 2009-07-25 2015-05-27 Fleur T Tehrani Automatic control system for mechanical ventilation for active or passive subjects
WO2012080903A1 (en) 2010-12-17 2012-06-21 Koninklijke Philips Electronics N.V. System and method for customizable automated control of fraction of inspired oxygen and/or positive end expiratory pressure to maintain oxygenation
US9937308B2 (en) 2010-12-17 2018-04-10 Koninklijke Philips N.V. System and method for customizable automated control of fraction of inspired oxygen and/or positive end expiratory pressure to maintain oxygenation
US12053588B2 (en) 2014-12-31 2024-08-06 Vapotherm, Inc. Systems and methods for humidity control
US10514662B1 (en) 2015-01-22 2019-12-24 Vapotherm, Inc. Oxygen mixing and delivery
US11853084B1 (en) 2015-01-22 2023-12-26 Vapotherm, Inc. Oxygen mixing and delivery
US11092984B1 (en) 2015-01-22 2021-08-17 Vapotherm, Inc. Oxygen mixing and delivery
US11324954B2 (en) 2019-06-28 2022-05-10 Covidien Lp Achieving smooth breathing by modified bilateral phrenic nerve pacing
US12036409B2 (en) 2019-06-28 2024-07-16 Covidien Lp Achieving smooth breathing by modified bilateral phrenic nerve pacing
US11779720B2 (en) 2019-11-04 2023-10-10 Vapotherm, Inc. Methods, devices, and systems for improved oxygenation patient monitoring, mixing, and delivery
US11612706B2 (en) 2019-11-25 2023-03-28 John C. Taube Methods, systems, and devices for controlling mechanical ventilation
US12064562B2 (en) 2020-03-12 2024-08-20 Vapotherm, Inc. Respiratory therapy unit with non-contact sensing and control

Also Published As

Publication number Publication date
GB2423721B (en) 2008-11-12
GB2423721A (en) 2006-09-06
AU2004292955B2 (en) 2010-02-18
NZ546941A (en) 2009-01-31
WO2005051280A3 (en) 2006-05-26
CA2545570C (en) 2012-01-03
CA2545570A1 (en) 2005-06-09
GB0611065D0 (en) 2006-07-12
AU2004292955A1 (en) 2005-06-09
US7802571B2 (en) 2010-09-28
US20050109340A1 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
US7802571B2 (en) Method and apparatus for controlling a ventilator
US9604021B2 (en) Automatic control system for mechanical ventilation for active or passive subjects
JP5016595B2 (en) Apparatus and method for controlling inspiratory oxygen concentration
JP2023153858A (en) Methods and apparatus for oxygenation and/or co2 clearance
US9884159B2 (en) Method and system for controlling breathing
US8408203B2 (en) System and methods for ventilating a patient
AU757163B2 (en) Determining suitable ventilator settings for patients with alveolar hypoventilation during sleep
US20080202522A1 (en) Setting mandatory mechanical ventilation parameters based on patient physiology
US20080230062A1 (en) Setting expiratory time in mandatory mechanical ventilation based on a deviation from a stable condition of exhaled gas volumes
WO1992011052A1 (en) Anesthesia emergence system using closed-loop pco¿2?
US20080230061A1 (en) Setting expiratory time in mandatory mechanical ventilation based on a deviation from a stable condition of end tidal gas concentrations
US20080230064A1 (en) Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when forced inhalation flow ceases
US20080230060A1 (en) Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when tidal volume is inspired
EP1961378A1 (en) Setting mandatory mechanical ventilation parameters based on patient physiology
US20230157574A1 (en) End tidal carbon dioxide measurement during high flow oxygen therapy
Tehrani et al. Closed-loop control of artificial respiration
WO2015002662A1 (en) Method and system for controlling breathing

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004292955

Country of ref document: AU

Ref document number: 546941

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2545570

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

ENP Entry into the national phase

Ref document number: 2004292955

Country of ref document: AU

Date of ref document: 20041025

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004292955

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 0611065.4

Country of ref document: GB

Ref document number: 0611065

Country of ref document: GB

122 Ep: pct application non-entry in european phase